Constitutive	O
activation	O
of	O
NF-kappaB	B-protein
in	O
primary	B-cell_type
adult	I-cell_type
T-cell	I-cell_type
leukemia	I-cell_type
cells	I-cell_type
.	O

Human	O
T-cell	O
leukemia	O
virus	O
type	O
I	O
(	O
HTLV-I	O
)	O
is	O
an	O
etiologic	O
agent	O
of	O
adult	O
T-cell	O
leukemia	O
(	O
ATL	O
)	O
.	O

The	O
viral	B-protein
protein	I-protein
Tax	B-protein
induces	O
the	O
activation	O
and	O
nuclear	O
translocalization	O
of	O
transcription	B-protein
factor	I-protein
NF-kappaB	B-protein
,	O
which	O
is	O
proposed	O
to	O
play	O
a	O
crucial	O
role	O
in	O
the	O
transformation	O
of	O
T	B-cell_type
cells	I-cell_type
by	O
HTLV-I	O
.	O

However	O
,	O
the	O
HTLV-I	B-DNA
genes	I-DNA
including	O
Tax	B-protein
are	O
not	O
expressed	O
significantly	O
in	O
primary	B-cell_type
leukemic	I-cell_type
cells	I-cell_type
from	O
ATL	O
patients	O
.	O

In	O
this	O
study	O
,	O
we	O
examined	O
the	O
basis	O
for	O
NF-kappaB	B-protein
activation	O
in	O
freshly	B-cell_type
isolated	I-cell_type
leukemic	I-cell_type
cells	I-cell_type
from	O
ATL	O
patients	O
.	O

We	O
found	O
that	O
leukemic	B-cell_type
cells	I-cell_type
from	O
ATL	O
patients	O
,	O
like	O
HTLV-I-infected	B-cell_line
T-cell	I-cell_line
lines	I-cell_line
,	O
display	O
constitutive	O
NF-kappaB	B-protein
DNA	O
binding	O
activity	O
and	O
increased	O
degradation	O
of	O
IkappaBalpha	B-protein
(	O
an	O
inhibitor	O
of	O
NF-kappaB	B-protein
)	O
.	O

Whereas	O
the	O
NF-kappaB	B-protein
binding	O
activity	O
in	O
Tax-expressing	B-cell_line
T-cell	I-cell_line
lines	I-cell_line
consisted	O
mostly	O
of	O
p50/c-Rel	B-protein
,	O
fresh	O
ATL	O
samples	O
contained	O
p50/p50	B-protein
and	I-protein
p50/p65	I-protein
heterodimers	I-protein
.	O

One	O
T-cell	B-cell_line
line	I-cell_line
derived	O
from	O
ATL	O
leukemic	B-cell_type
cells	I-cell_type
,	O
TL-Om1	O
,	O
displayed	O
constitutive	O
NF-kappaB	B-protein
activity	O
,	O
as	O
well	O
as	O
enhanced	O
degradation	O
of	O
IkappaBalpha	B-protein
,	O
despite	O
the	O
lack	O
of	O
detectable	O
Tax	B-protein
expression	O
.	O

Interestingly	O
,	O
the	O
NF-kappaB	B-protein
in	O
TL-Om1	O
consists	O
of	O
p50/p50	B-protein
and	O
p50/p65	B-protein
like	O
that	O
in	O
fresh	O
primary	B-cell_type
leukemic	I-cell_type
cells	I-cell_type
.	O

Our	O
results	O
suggest	O
that	O
activation	O
of	O
NF-kappaB	B-protein
occurs	O
through	O
a	O
Tax	B-protein
-independent	O
mechanism	O
in	O
leukemic	B-cell_type
cells	I-cell_type
of	O
ATL	O
patients	O
,	O
possibly	O
due	O
to	O
differential	O
NF-kappaB	B-protein
subunit	O
activation	O
.	O

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

NEOPLASIA	NULL
Constitutive	NULL
Activation	NULL
of	NULL
NF-B	NULL
in	NULL
Primary	NULL
Adult	NULL
T-Cell	NULL
Leukemia	NULL
Cells	NULL
By	NULL
Naoki	NULL
Mori	NULL
,	NULL
Masahiro	NULL
Fujii	NULL
,	NULL
Shuichi	NULL
Ikeda	NULL
,	NULL
Yasuaki	NULL
Yamada	NULL
,	NULL
Masao	NULL
Tomonaga	NULL
,	NULL
Dean	NULL
W.	NULL
Ballard	NULL
,	NULL
and	NULL
Naoki	NULL
Yamamoto	NULL
Human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
|	NULL
(	NULL
HTLV-I	NULL
)	NULL
is	NULL
an	NULL
etiologic	NULL
agent	NULL
of	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
(	NULL
ATL	NULL
)	NULL
.	NULL

The	NULL
viral	NULL
protein	NULL
Tax	NULL
induces	NULL
the	NULL
activation	NULL
and	NULL
nuclear	NULL
translocalization	NULL
of	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
which	NULL
is	NULL
proposed	NULL
to	NULL
play	NULL
a	NULL
crucial	NULL
role	NULL
in	NULL
the	NULL
transformation	NULL
of	NULL
T	NULL
cells	NULL
by	NULL
HTLV-I	NULL
.	NULL

However	NULL
,	NULL
the	NULL
HTLV-I	NULL
genes	NULL
including	NULL
Tax	NULL
are	NULL
not	NULL
expressed	NULL
significantly	NULL
in	NULL
primary	NULL
leukemic	NULL
cells	NULL
from	NULL
ATL	NULL
patients	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
basis	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
freshly	NULL
isolated	NULL
leukemic	NULL
cells	NULL
from	NULL
ATL	NULL
patients	NULL
.	NULL

We	NULL
found	NULL
that	NULL
leukemic	NULL
cells	NULL
from	NULL
ATL	NULL
patients	NULL
,	NULL
like	NULL
HTLV-l-infected	NULL
T-cell	NULL
lines	NULL
,	NULL
display	NULL
constitutive	NULL
NF-kB	NULL
DNA	NULL
binding	NULL
activity	NULL
and	NULL
increased	NULL
degradation	NULL
of	NULL
(	NULL
an	NULL
inhibitor	NULL
of	NULL
NF-kB	NULL
)	NULL
.	NULL

Whereas	NULL
DULT	NULL
T-CELL	NULL
leukemia	NULL
(	NULL
ATL	NULL
)	NULL
is	NULL
a	NULL
highly	NULL
aggressive	NULL
T-cell	NULL
malignancy	NULL
etiologically	NULL
linked	NULL
to	NULL
a	NULL
retrovirus	NULL
,	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
(	NULL
HTLV-I	NULL
)	NULL
.	NULL

As	NULL
the	NULL
viral	NULL
genome	NULL
does	NULL
not	NULL
encode	NULL
a	NULL
known	NULL
oncogene	NULL
``	NULL
or	NULL
promote	NULL
cis-activation	NULL
of	NULL
endogenous	NULL
proto-oncogenes	NULL
by	NULL
site-specific	NULL
integration	NULL
,	NULL
``	NULL
the	NULL
events	NULL
leading	NULL
to	NULL
the	NULL
occurrence	NULL
and	NULL
progression	NULL
of	NULL
this	NULL
hematologic	NULL
disease	NULL
remain	NULL
to	NULL
be	NULL
elucidated	NULL
.	NULL

A	NULL
40-kD	NULL
nuclear	NULL
oncoprotein	NULL
,	NULL
termed	NULL
Tax	NULL
,	NULL
appears	NULL
to	NULL
be	NULL
responsible	NULL
for	NULL
the	NULL
transforming	NULL
features	NULL
of	NULL
HTLV-I	NULL
.	NULL

HTLV-I	NULL
Tax	NULL
is	NULL
a	NULL
potent	NULL
transcriptional	NULL
activator	NULL
of	NULL
the	NULL
HTLV-I	NULL
long	NULL
terminal	NULL
repeat	NULL
,	NULL
``	NULL
as	NULL
well	NULL
as	NULL
numerous	NULL
cellular	NULL
genes	NULL
involved	NULL
in	NULL
T-cell	NULL
activation	NULL
and	NULL
growth	NULL
,	NULL
such	NULL
as	NULL
those	NULL
encoding	NULL
interleukin-2	NULL
(	NULL
IL-2	NULL
)	NULL
``	NULL
*	NULL
and	NULL
the	NULL
a	NULL
chain	NULL
of	NULL
IL-2	NULL
receptor	NULL
(	NULL
IL-2Ra	NULL
)	NULL
.	NULL

!	NULL
``	NULL

Because	NULL
Tax	NULL
does	NULL
not	NULL
bind	NULL
DNA	NULL
directly	NULL
,	NULL
Tax	NULL
appears	NULL
to	NULL
induce	NULL
cellular	NULL
target	NULL
genes	NULL
indirectly	NULL
via	NULL
host	NULL
cellular	NULL
pathways	NULL
,	NULL
``	NULL
including	NULL
activation	NULL
of	NULL
the	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

!	NULL

*	NULL
!	NULL

4	NULL
In	NULL
resting	NULL
T	NULL
cells	NULL
,	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

proteins	NULL
are	NULL
sequestered	NULL
in	NULL
the	NULL
cytoplasm	NULL
as	NULL
latent	NULL
precursors	NULL
by	NULL
their	NULL
inhibitor	NULL
,	NULL
IxBa	NULL
.	NULL
``	NULL

From	NULL
the	NULL
Department	NULL
of	NULL
Preventive	NULL
Medicine	NULL
and	NULL
AIDS	NULL
Research	NULL
,	NULL
Research	NULL
Field	NULL
of	NULL
Pathogenesis	NULL
and	NULL
Clinical	NULL
Sciences	NULL
,	NULL
Institute	NULL
of	NULL
Tropical	NULL
Medicine	NULL
,	NULL
Nagasaki	NULL
University	NULL
,	NULL
the	NULL
Department	NULL
of	NULL
Laboratory	NULL
Medicine	NULL
,	NULL
Nagasaki	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
the	NULL
Department	NULL
of	NULL
Hematology	NULL
,	NULL
Atomic	NULL
Disease	NULL
Institute	NULL
,	NULL
Nagasaki	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Nagasaki	NULL
;	NULL
the	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
City	NULL
of	NULL
Sasebo	NULL
General	NULL
Hospital	NULL
,	NULL
Sasebo	NULL
;	NULL
the	NULL
Department	NULL
of	NULL
Virology	NULL
,	NULL
Niigata	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Niigata	NULL
,	NULL
Japan	NULL
;	NULL
and	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
,	NULL
Vanderbilt	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Nashville	NULL
,	NULL
TN	NULL
.	NULL

Submitted	NULL
July	NULL
29	NULL
,	NULL
1998	NULL
;	NULL
accepted	NULL
November	NULL
22	NULL
,	NULL
1998	NULL
.	NULL

Supported	NULL
in	NULL
part	NULL
by	NULL
a	NULL
Grant	NULL
in	NULL
Aid	NULL
for	NULL
Scientific	NULL
Research	NULL
from	NULL
the	NULL
Ministry	NULL
of	NULL
Education	NULL
,	NULL
Science	NULL
and	NULL
Culture	NULL
,	NULL
Japan	NULL
,	NULL
and	NULL
a	NULL
Cooperative	NULL
Research	NULL
Grant	NULL
No	NULL
.	NULL

1998-10-A-14	NULL
from	NULL
the	NULL
Institute	NULL
of	NULL
Tropical	NULL
Medicine	NULL
,	NULL
Nagasaki	NULL
University	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
Naoki	NULL
Mori	NULL
,	NULL
MD	NULL
,	NULL
Department	NULL
of	NULL
Preventive	NULL
Medicine	NULL
and	NULL
AIDS	NULL
Research	NULL
,	NULL
Research	NULL
Field	NULL
of	NULL
Pathogenesis	NULL
and	NULL
Clinical	NULL
Sciences	NULL
,	NULL
Institute	NULL
of	NULL
Tropical	NULL
Medicine	NULL
,	NULL
Nagasaki	NULL
University	NULL
,	NULL
1-12-4	NULL
Sakamoto	NULL
,	NULL
Nagasaki	NULL
852-8523	NULL
,	NULL
Japan	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
adver-tisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-4971/99/9307-0015	NULL
$	NULL
3.00/0	NULL
2360	NULL
the	NULL
NF-kB	NULL
binding	NULL
activity	NULL
in	NULL
Tax-expressing	NULL
T-cell	NULL
lines	NULL
consisted	NULL
mostly	NULL
of	NULL
p50/	NULL
c-Rel	NULL
,	NULL
fresh	NULL
ATL	NULL
samples	NULL
contained	NULL
p50/	NULL
p50	NULL
and	NULL
p50/p65	NULL
heterodimers	NULL
.	NULL

One	NULL
T-cell	NULL
line	NULL
derived	NULL
from	NULL
ATL	NULL
leukemic	NULL
cells	NULL
,	NULL
TL-Om1	NULL
,	NULL
displayed	NULL
constitutive	NULL
activity	NULL
,	NULL
as	NULL
well	NULL
as	NULL
enhanced	NULL
degradation	NULL
of	NULL
despite	NULL
the	NULL
lack	NULL
of	NULL
detectable	NULL
Tax	NULL
expression	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
TL-Om1	NULL
consists	NULL
of	NULL
p50/	NULL
p50	NULL
and	NULL
p50/	NULL
p65	NULL
like	NULL
that	NULL
in	NULL
fresh	NULL
primary	NULL
leukemic	NULL
cells	NULL
.	NULL

Our	NULL
results	NULL
suggest	NULL
that	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
occurs	NULL
through	NULL
a	NULL
Tax-independent	NULL
mechanism	NULL
in	NULL
leukemic	NULL
cells	NULL
of	NULL
ATL	NULL
patients	NULL
,	NULL
possibly	NULL
due	NULL
to	NULL
differential	NULL
NF-kB	NULL
subunit	NULL
activation	NULL
.	NULL

©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

Subsequent	NULL
to	NULL
cellular	NULL
activation	NULL
and	NULL
through	NULL
proteolytic	NULL
degradation	NULL
of	NULL
IxBa	NULL
,	NULL
NF-kB	NULL
is	NULL
released	NULL
and	NULL
translocates	NULL
to	NULL
the	NULL
nucleus	NULL
where	NULL
it	NULL
transactivates	NULL
several	NULL
genes	NULL
,	NULL
including	NULL
IxBa	NULL
itself	NULL
.	NULL
``	NULL

''	NULL
Recent	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
Tax	NULL
induces	NULL
the	NULL
degradation	NULL
of	NULL
IxBa	NULL
,	NULL
which	NULL
may	NULL
contribute	NULL
to	NULL
constitutive	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
HTLV-L-infected	NULL
T-cell	NULL
lines	NULL
.	NULL
``	NULL

''	NULL
Although	NULL
NF-kB	NULL
is	NULL
known	NULL
to	NULL
be	NULL
constitutively	NULL
activated	NULL
in	NULL
Tax-expressing	NULL
and	NULL
HTLV-I-infected	NULL
T-cell	NULL
lines	NULL
,	NULL
the	NULL
activation	NULL
status	NULL
of	NULL
NF-KB	NULL
in	NULL
leukemic	NULL
cells	NULL
from	NULL
ATL	NULL
patients	NULL
remains	NULL
unclear	NULL
.	NULL

Some	NULL
of	NULL
the	NULL
genes	NULL
that	NULL
can	NULL
be	NULL
transactivated	NULL
by	NULL
Tax	NULL
are	NULL
constitutively	NULL
expressed	NULL
in	NULL
leukemic	NULL
cells	NULL
from	NULL
ATL	NULL
patients	NULL
.	NULL

On	NULL
isolation	NULL
,	NULL
ATL	NULL
cells	NULL
spontaneously	NULL
display	NULL
surface	NULL
IL-2Ra	NULL
``	NULL
and	NULL
express	NULL
mRNA	NULL
for	NULL
cytokines	NULL
including	NULL
IL-1	NULL
«	NULL
,	NULL
``	NULL
>	NULL
*	NULL
IL-18,2	NULL
>	NULL
2	NULL
IL-6,2	NULL
%	NULL
2	NULL
``	NULL
IL-8	NULL
,	NULL
``	NULL
IL-9	NULL
,	NULL
``	NULL
IL-10	NULL
,	NULL
``	NULL
°	NULL
tumor	NULL
necrosis	NULL
factor	NULL
B	NULL
,	NULL
``	NULL
transforming	NULL
growth	NULL
factor	NULL
3	NULL
,	NULL
*	NULL
>	NULL
>	NULL
``	NULL
and	NULL
parathyroid	NULL
hormone-related	NULL
protein	NULL
.	NULL

``	NULL
*	NULL
``	NULL
``	NULL
Among	NULL
them	NULL
,	NULL
genes	NULL
for	NULL
IL-1	NULL
@	NULL
,	NULL
``	NULL
°	NULL
IL-6	NULL
,	NULL
*	NULL
``	NULL
IL-8,2	NULL
``	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor	NULL
B	NULL
``	NULL
``	NULL
harbor	NULL
the	NULL
xB	NULL
enhancer	NULL
element	NULL
and	NULL
Tax	NULL
activates	NULL
transcription	NULL
of	NULL
these	NULL
cellular	NULL
genes	NULL
through	NULL
NF-KB	NULL
binding	NULL
site	NULL
.	NULL

However	NULL
,	NULL
primary	NULL
leukemic	NULL
cells	NULL
isolated	NULL
from	NULL
ATL	NULL
patients	NULL
typically	NULL
express	NULL
Tax	NULL
mRNA	NULL
and	NULL
protein	NULL
at	NULL
low	NULL
levels	NULL
,	NULL
if	NULL
at	NULL
These	NULL
findings	NULL
imply	NULL
that	NULL
there	NULL
is	NULL
another	NULL
mechanism	NULL
independent	NULL
of	NULL
Tax	NULL
underlying	NULL
the	NULL
overexpression	NULL
of	NULL
several	NULL
cellular	NULL
genes	NULL
in	NULL
fresh	NULL
ATL	NULL
cells	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
IxBa	NULL
in	NULL
leukemic	NULL
cells	NULL
isolated	NULL
from	NULL
ATL	NULL
patients	NULL
and	NULL
in	NULL
control	NULL
cells	NULL
from	NULL
healthy	NULL
subjects	NULL
.	NULL

Tax	NULL
expression	NULL
in	NULL
the	NULL
primary	NULL
cells	NULL
isolated	NULL
from	NULL
these	NULL
patients	NULL
was	NULL
hard	NULL
to	NULL
estimate	NULL
quantitatively	NULL
with	NULL
Northern	NULL
and	NULL
Western	NULL
blot	NULL
analyses	NULL
.	NULL

We	NULL
found	NULL
evidence	NULL
for	NULL
constitutive	NULL
degradation	NULL
of	NULL
IxBa	NULL
protein	NULL
,	NULL
increased	NULL
nuclear	NULL
expression	NULL
of	NULL
NF-KB	NULL
,	NULL
and	NULL
increased	NULL
expression	NULL
of	NULL
IxBa	NULL
mRNA	NULL
in	NULL
ATL	NULL
cells	NULL
.	NULL

Also	NULL
,	NULL
TL-Om1	NULL
,	NULL
which	NULL
does	NULL
not	NULL
express	NULL
Tax	NULL
at	NULL
all	NULL
,	NULL
still	NULL
exhibits	NULL
constitutive	NULL
NF-KB	NULL
binding	NULL
activity	NULL
,	NULL
composed	NULL
of	NULL
p50	NULL
and	NULL
p65	NULL
,	NULL
as	NULL
seen	NULL
in	NULL
ATL	NULL
cells	NULL
.	NULL

These	NULL
observations	NULL
suggest	NULL
Tax-independent	NULL
mechanisms	NULL
operating	NULL
for	NULL
constitutive	NULL
NF-kB	NULL
activation	NULL
in	NULL
leukemic	NULL
cells	NULL
from	NULL
ATL	NULL
patients	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cells	NULL
.	NULL

MT-2	NULL
,	NULL
HUT-102	NULL
,	NULL
SLB-1	NULL
,	NULL
C5/MJ	NULL
,	NULL
and	NULL
TL-Om	NULL
!	NULL

1	NULL
are	NULL
human	NULL
T-cell	NULL
lines	NULL
infected	NULL
with	NULL
HTLV-I	NULL
.	NULL

Jurkat	NULL
,	NULL
MOLT-4	NULL
,	NULL
and	NULL
H-9	NULL
are	NULL
human	NULL
T-cell	NULL
lines	NULL
.	NULL

These	NULL
T-cell	NULL
lines	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
,	NULL
glutamine	NULL
,	NULL
and	NULL
antibiotics	NULL
.	NULL

Blood	NULL
,	NULL
Vol	NULL
93	NULL
,	NULL
No	NULL
7	NULL
(	NULL
April	NULL
1	NULL
)	NULL
,	NULL
1999	NULL
;	NULL
pp	NULL
2360-2368	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

NF-kB	NULL
ACTIVATION	NULL
IN	NULL
ATL	NULL
JPX-9	NULL
is	NULL
a	NULL
derivative	NULL
of	NULL
Jurkat	NULL
cells	NULL
carrying	NULL
the	NULL
transfected	NULL
Tax	NULL
gene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
metallothionein	NULL
promoter	NULL
.	NULL
``	NULL

Expression	NULL
of	NULL
Tax	NULL
was	NULL
induced	NULL
by	NULL
adding	NULL
20	NULL
pmol/L	NULL
CdC	NULL
]	NULL
;	NULL
into	NULL
the	NULL
medium	NULL
.	NULL

Peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
(	NULL
PBMC	NULL
)	NULL
from	NULL
7	NULL
patients	NULL
,	NULL
5	NULL
with	NULL
acute-type	NULL
ATL	NULL
(	NULL
patients	NULL
3	NULL
to	NULL
7	NULL
)	NULL
and	NULL
2	NULL
with	NULL
chronic	NULL
type	NULL
ATL	NULL
(	NULL
patients	NULL
1	NULL
and	NULL
2	NULL
)	NULL
,4	NULL
were	NULL
analyzed	NULL
.	NULL

The	NULL
diagnosis	NULL
of	NULL
ATL	NULL
was	NULL
based	NULL
on	NULL
clinical	NULL
features	NULL
,	NULL
hematologic	NULL
characteristics	NULL
,	NULL
the	NULL
presence	NULL
of	NULL
serum	NULL
antibodies	NULL
to	NULL
ATL-associated	NULL
antigens	NULL
,	NULL
and	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
HTLV-I	NULL
proviral	NULL
genome	NULL
in	NULL
DNA	NULL
from	NULL
leukemic	NULL
cells	NULL
PBMC	NULL
were	NULL
isolated	NULL
by	NULL
Ficoll/Hypaque	NULL
(	NULL
Pharmacia	NULL
LKB	NULL
,	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
)	NULL
by	NULL
density	NULL
gradient	NULL
centrifugation	NULL
.	NULL

Each	NULL
patient	NULL
had	NULL
more	NULL
than	NULL
90	NULL
%	NULL
leukemic	NULL
cells	NULL
in	NULL
the	NULL
blood	NULL
at	NULL
the	NULL
time	NULL
of	NULL
analysis	NULL
.	NULL

Detection	NULL
of	NULL
IL-2Ra-positive	NULL
cells	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
washed	NULL
once	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
containing	NULL
0.1	NULL
%	NULL
NaN	NULL
;	NULL
and	NULL
mixed	NULL
with	NULL
fluorescein	NULL
isothiocyanate-conjugated	NULL
murine	NULL
monoclonal	NULL
antibody	NULL
to	NULL
the	NULL
a	NULL
chain	NULL
of	NULL
the	NULL
human	NULL
IL-2R	NULL
.	NULL

After	NULL
incubation	NULL
for	NULL
30	NULL
minutes	NULL
at	NULL
4°C	NULL
,	NULL
they	NULL
were	NULL
washed	NULL
with	NULL
PBS	NULL
containing	NULL
0.1	NULL
%	NULL
NaN3	NULL
and	NULL
then	NULL
analyzed	NULL
using	NULL
a	NULL
FACScan	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
San	NULL
Jose	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
extracted	NULL
from	NULL
cells	NULL
using	NULL
the	NULL
Trizol	NULL
method	NULL
as	NULL
described	NULL
by	NULL
the	NULL
manufacturer	NULL
(	NULL
GIBCO-BRL	NULL
,	NULL
Gaithersburg	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

Twenty	NULL
micrograms	NULL
of	NULL
RNA	NULL
was	NULL
electrophoresed	NULL
through	NULL
a	NULL
formaldehyde-agarose	NULL
gel	NULL
and	NULL
transferred	NULL
to	NULL
a	NULL
nylon	NULL
mem-brane	NULL
.	NULL

Membranes	NULL
were	NULL
prehybridized	NULL
(	NULL
0.5	NULL
mol/L	NULL
sodium	NULL
phosphate	NULL
,	NULL
0.1	NULL
%	NULL
bovine	NULL
serum	NULL
albumin	NULL
,	NULL
7	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
[	NULL
SDS	NULL
]	NULL
,	NULL
100	NULL
ug/mL	NULL
salmon	NULL
testis	NULL
DNA	NULL
,	NULL
and	NULL
100	NULL
ug/mL	NULL
yeast	NULL
RNA	NULL
)	NULL
for	NULL
2	NULL
hours	NULL
at	NULL
65°C	NULL
and	NULL
then	NULL
hybridized	NULL
overnight	NULL
with	NULL
the	NULL
following	NULL
[	NULL
a-	NULL
``	NULL
°P	NULL
]	NULL
radiolabeled	NULL
probes	NULL
:	NULL
cDNA	NULL
of	NULL
human	NULL
IL-2Ra	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
Dr	NULL
T.	NULL
Taniguchi	NULL
,	NULL
Tokyo	NULL
University	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
,	NULL
``	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
(	NULL
GAPDH	NULL
)	NULL
,	NULL
and	NULL
HTLV-I	NULL
Tax	NULL
.	NULL

Radiolabeled	NULL
probes	NULL
were	NULL
generated	NULL
by	NULL
using	NULL
a	NULL
Megaprime	NULL
DNA	NULL
Labeling	NULL
system	NULL
(	NULL
Amersham	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
.	NULL

Western	NULL
blotting	NULL
.	NULL

The	NULL
antibody	NULL
used	NULL
in	NULL
these	NULL
experiments	NULL
was	NULL
rabbit	NULL
polyclonal	NULL
antibody	NULL
to	NULL
IxBa	NULL
«	NULL
,	NULL
C-21	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
lysed	NULL
by	NULL
incubation	NULL
in	NULL
radio-immuno-protein-assay	NULL
(	NULL
RIPA	NULL
)	NULL
buffer	NULL
(	NULL
0.5	NULL
%	NULL
sodjumdeoxycholate	NULL
,	NULL
1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
,	NULL
66	NULL
ug/mL	NULL
aprotinin	NULL
,	NULL
100	NULL
ug/mL	NULL
phenyImethylsulfonyl	NULL
fluoride	NULL
,	NULL
and	NULL
1	NULL
mmol/L	NULL
sodium	NULL
orthovanadate	NULL
)	NULL
for	NULL
30	NULL
minutes	NULL
at	NULL
4°C	NULL
.	NULL

Equal	NULL
amounts	NULL
(	NULL
50	NULL
ug	NULL
)	NULL
of	NULL
protein	NULL
from	NULL
cell	NULL
lysates	NULL
were	NULL
electrophoresed	NULL
on	NULL
10	NULL
%	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
gels	NULL
and	NULL
transferred	NULL
to	NULL
polyvinylidine	NULL
difluoride	NULL
membranes	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
washed	NULL
with	NULL
Tris-buffered	NULL
saline-Tween	NULL
(	NULL
0.05	NULL
%	NULL
)	NULL
with	NULL
3	NULL
%	NULL
nonfat	NULL
dried	NULL
milk	NULL
overnight	NULL
at	NULL
4°C	NULL
and	NULL
then	NULL
blotted	NULL
for	NULL
45	NULL
minutes	NULL
with	NULL
the	NULL
antibody	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
washed	NULL
with	NULL
Tris-buffered	NULL
saline-Tween	NULL
and	NULL
incubated	NULL
with	NULL
a	NULL
1:5,000	NULL
dilution	NULL
of	NULL
horseradish	NULL
peroxidase-conjugated	NULL
antirabbit	NULL
immunoglobulin	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

Thereafter	NULL
,	NULL
membranes	NULL
were	NULL
developed	NULL
with	NULL
enhanced	NULL
chemiluminescence	NULL
reagents	NULL
(	NULL
Amersham	NULL
)	NULL
and	NULL
exposed	NULL
to	NULL
film	NULL
.	NULL

Oligonucleotides	NULL
.	NULL

-	NULL
The	NULL
sequence	NULL
of	NULL
the	NULL
oligonucleotide	NULL
corresponding	NULL
to	NULL
the	NULL
xB	NULL
element	NULL
from	NULL
IL-2Ra	NULL
«	NULL
gene	NULL
was	NULL
5'-gatcCGGCAGGG-GAATCTCCCTCTC-3	NULL
'	NULL
.	NULL
``	NULL

Underlined	NULL
sequences	NULL
represent	NULL
the	NULL
<	NULL
B	NULL
motif	NULL
.	NULL

The	NULL
oligonucleotide	NULL
,	NULL
5'-gatcTGTCGAATGCAAATCACTAGAA-3	NULL
'	NULL
,	NULL
containing	NULL
the	NULL
consensus	NULL
sequence	NULL
of	NULL
the	NULL
octamer	NULL
binding	NULL
motif	NULL
(	NULL
underlined	NULL
)	NULL
was	NULL
used	NULL
to	NULL
identify	NULL
specific	NULL
binding	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
Oct-1	NULL
.	NULL

This	NULL
transcription	NULL
factor	NULL
regulates	NULL
transcription	NULL
of	NULL
a	NULL
number	NULL
of	NULL
so-called	NULL
housekeeping	NULL
genes	NULL
.	NULL

For	NULL
competition	NULL
studies	NULL
,	NULL
oligonucleotides	NULL
containing	NULL
mutant	NULL
xB	NULL
and	NULL
two	NULL
xB	NULL
motifs	NULL
derived	NULL
from	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
were	NULL
used	NULL
,	NULL
and	NULL
the	NULL
sequences	NULL
are	NULL
5'-gatcCGGCAGatctATCTC-CCTCTC-3	NULL
'	NULL
and	NULL
5'-gatcACAAGGGACTTTCCGCTGGGGACTTT	NULL
CCAG-3	NULL
'	NULL
,	NULL
respectively	NULL
.	NULL

For	NULL
the	NULL
preparation	NULL
of	NULL
a	NULL
probe	NULL
in	NULL
electrophoretic	NULL
ability	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
,	NULL
a	NULL
radiolabeled	NULL
double-stranded	NULL
oligonucleotide	NULL
was	NULL
prepared	NULL
by	NULL
annealing	NULL
and	NULL
filling	NULL
in	NULL
the	NULL
overhang	NULL
with	NULL
the	NULL
Klenow	NULL
fragment	NULL
of	NULL
DNA	NULL
polymerase	NULL
I	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
[	NULL
e-	NULL
``	NULL
P	NULL
]	NULL
deoxycytidine	NULL
triphosphate	NULL
(	NULL
dCTP	NULL
)	NULL
and	NULL
[	NULL
«	NULL
-P	NULL
]	NULL
deoxyadenosine	NULL
triphosphate	NULL
(	NULL
dATP	NULL
)	NULL
.	NULL

2361	NULL
Preparation	NULL
of	NULL
nuclear	NULL
extracts	NULL
.	NULL

-	NULL
Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
by	NULL
Antalis	NULL
et	NULL
al	NULL
``	NULL
``	NULL
with	NULL
modifications	NULL
.	NULL

Cells	NULL
(	NULL
10	NULL
``	NULL
)	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
cold	NULL
PBS	NULL
and	NULL
the	NULL
cell	NULL
pellet	NULL
was	NULL
suspended	NULL
in	NULL
400	NULL
uL	NULL
of	NULL
hypotonic	NULL
buffer	NULL
A	NULL
(	NULL
10	NULL
mmol/L	NULL
HEPES	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
10	NULL
mmol/L	NULL
KCI	NULL
,	NULL
0.1	NULL
mmol/L	NULL
EDTA	NULL
,	NULL
0.1	NULL
mmol/L	NULL
EGTA	NULL
,	NULL
1	NULL
mmol/L	NULL
dithiothreitol	NULL
[	NULL
DTT	NULL
]	NULL
,	NULL
2	NULL
mmol/L	NULL
aminoethyl-benzenesulfonyl	NULL
fluoride	NULL
[	NULL
AEBSF	NULL
]	NULL
,	NULL
and	NULL
0.2	NULL
%	NULL
Nonidet	NULL
P-40	NULL
)	NULL
for	NULL
10	NULL
minutes	NULL
at	NULL
4°C	NULL
.	NULL

Nuclei	NULL
were	NULL
prepared	NULL
by	NULL
microcentrifugation	NULL
for	NULL
5	NULL
minutes	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
nuclear	NULL
pellet	NULL
was	NULL
suspended	NULL
in	NULL
75	NULL
uL	NULL
of	NULL
buffer	NULL
C	NULL
(	NULL
20	NULL
mmol/L	NULL
HEPES	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
0.4	NULL
mol/L	NULL
NaC	NULL
]	NULL
,	NULL
1	NULL
mmol/L	NULL
EDTA	NULL
,	NULL
1	NULL
mmol/L	NULL
EGTA	NULL
,	NULL
1	NULL
mmol/L	NULL
DTT	NULL
,	NULL
2	NULL
mmol/L	NULL
AEBSE	NULL
,	NULL
33	NULL
ug/mL	NULL
aprotinin	NULL
,	NULL
10	NULL
ug/mL	NULL
leupeptin	NULL
,	NULL
10	NULL
ug/mL	NULL
E-64	NULL
,	NULL
and	NULL
10	NULL
ug/mL	NULL
pepstatin	NULL
A	NULL
)	NULL
and	NULL
incubated	NULL
for	NULL
30	NULL
minutes	NULL
at	NULL
4°C	NULL
with	NULL
brief	NULL
mixing	NULL
.	NULL

The	NULL
mixture	NULL
was	NULL
microcentrifuged	NULL
(	NULL
15,000	NULL
cpm	NULL
)	NULL
for	NULL
15	NULL
minutes	NULL
at	NULL
4°C	NULL
.	NULL

Protein	NULL
concentration	NULL
was	NULL
measured	NULL
by	NULL
using	NULL
the	NULL
Bradford	NULL
assay	NULL
(	NULL
Bio-Rad	NULL
,	NULL
Richmond	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

EMSA	NULL
.	NULL

-	NULL
As	NULL
previously	NULL
described	NULL
,	NULL
``	NULL
nuclear	NULL
extracts	NULL
(	NULL
5	NULL
ug	NULL
of	NULL
protein	NULL
)	NULL
were	NULL
preincubated	NULL
in	NULL
a	NULL
20-uL	NULL
total	NULL
reaction	NULL
volume	NULL
containing	NULL
10	NULL
mmol/L	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
50	NULL
mmol/L	NULL
NaCl	NULL
,	NULL
1	NULL
mmol/L	NULL
EDTA	NULL
,	NULL
1	NULL
mmol/L	NULL
DTT	NULL
,	NULL
5	NULL
%	NULL
glycerol	NULL
,	NULL
and	NULL
1	NULL
ug	NULL
of	NULL
polydeoxyinosinic-deoxycyti-dylic	NULL
acid	NULL
(	NULL
Pharmacia	NULL
,	NULL
Piscataway	NULL
,	NULL
NJ	NULL
)	NULL
for	NULL
15	NULL
minutes	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

The	NULL
reaction	NULL
mixture	NULL
was	NULL
then	NULL
incubated	NULL
with	NULL
the	NULL
radiolabeled	NULL
oligonucleotide	NULL
(	NULL
50,000	NULL
cpm	NULL
)	NULL
for	NULL
15	NULL
minutes	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
analyzed	NULL
by	NULL
electrophoresis	NULL
in	NULL
a	NULL
4	NULL
%	NULL
nondenatur-ing	NULL
polyacrylamide	NULL
gel	NULL
with	NULL
0.25	NULL
X	NULL
TBE	NULL
buffer	NULL
(	NULL
22.3	NULL
mmol/L	NULL
Tris	NULL
,	NULL
22.2	NULL
mmol/L	NULL
boric	NULL
acid	NULL
,	NULL
and	NULL
0.5	NULL
mmol/L	NULL
EDTA	NULL
)	NULL
.	NULL

The	NULL
gels	NULL
were	NULL
dried	NULL
and	NULL
analyzed	NULL
by	NULL
autoradiography	NULL
.	NULL

Plasmids	NULL
and	NULL
transfection	NULL
.	NULL

-	NULL
A	NULL
reporter	NULL
plasmid	NULL
«	NULL
B-LUC	NULL
(	NULL
a	NULL
kind	NULL
gift	NULL
from	NULL
Dr	NULL
J.	NULL
Fujisawa	NULL
,	NULL
Kansai	NULL
Medical	NULL
University	NULL
,	NULL
Osaka	NULL
,	NULL
Japan	NULL
)	NULL
was	NULL
constructed	NULL
by	NULL
inserting	NULL
five	NULL
repeats	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sequence	NULL
of	NULL
the	NULL
IL-2Ra	NULL
gene	NULL
fused	NULL
to	NULL
an	NULL
enhancerless	NULL
promoter	NULL
of	NULL
HTLV-I	NULL
into	NULL
pGL2-Basic	NULL
containing	NULL
the	NULL
luciferase	NULL
gene	NULL
,	NULL
dN-LUC	NULL
.	NULL
``	NULL

'	NULL
The	NULL
NF-	NULL
«	NULL
B	NULL
expression	NULL
plasmids	NULL
,	NULL
human	NULL
p50	NULL
,	NULL
p65	NULL
,	NULL
and	NULL
c-Rel	NULL
,	NULL
were	NULL
the	NULL
generous	NULL
gifts	NULL
of	NULL
Dr	NULL
K.	NULL
Yamamoto	NULL
(	NULL
Kanazawa	NULL
University	NULL
,	NULL
Kanazawa	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

Transfections	NULL
were	NULL
performed	NULL
by	NULL
electroporation	NULL
.	NULL
``	NULL

''	NULL
In	NULL
all	NULL
cases	NULL
,	NULL
the	NULL
reference	NULL
plasmid	NULL
pRL-CMV	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
Renilla	NULL
luciferase	NULL
gene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
cytomegalovirus	NULL
immediate	NULL
early	NULL
enhancer/	NULL
promoter	NULL
,	NULL
was	NULL
cotransfected	NULL
to	NULL
correct	NULL
for	NULL
transfection	NULL
efficiency	NULL
.	NULL

For	NULL
luciferase	NULL
assay	NULL
,	NULL
the	NULL
transfected	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
a	NULL
lysis	NULL
reagent	NULL
(	NULL
Toyo	NULL
Ink	NULL
Co	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
,	NULL
and	NULL
luciferase	NULL
activities	NULL
were	NULL
measured	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
procedures	NULL
.	NULL

Each	NULL
assay	NULL
was	NULL
independently	NULL
repeated	NULL
at	NULL
least	NULL
three	NULL
times	NULL
.	NULL

RESULTS	NULL
HTLV-L-infected	NULL
T-cell	NULL
lines	NULL
constitutively	NULL
express	NULL
a	NULL
factor	NULL
mediating	NULL
activation	NULL
of	NULL
NF-xB	NULL
element	NULL
.	NULL

-	NULL
As	NULL
an	NULL
initial	NULL
test	NULL
of	NULL
the	NULL
activity	NULL
of	NULL
NF-kB	NULL
in	NULL
HTLV-I-infected	NULL
T-cell	NULL
lines	NULL
,	NULL
a	NULL
transfection	NULL
analysis	NULL
was	NULL
performed	NULL
using	NULL
a	NULL
reporter	NULL
construct	NULL
,	NULL
containing	NULL
a	NULL
luciferase	NULL
gene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
NF-kB	NULL
binding	NULL
site	NULL
from	NULL
the	NULL
IL-2Ra	NULL
gene	NULL
.	NULL

The	NULL
level	NULL
of	NULL
luciferase	NULL
activity	NULL
detected	NULL
in	NULL
uninfected	NULL
cells	NULL
transfected	NULL
with	NULL
«	NULL
B-LUC	NULL
was	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
cells	NULL
transfected	NULL
with	NULL
dN-LUC	NULL
(	NULL
Fig	NULL
1A	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
in	NULL
all	NULL
of	NULL
the	NULL
five	NULL
HTLV-I-infected	NULL
cell	NULL
lines	NULL
,	NULL
the	NULL
reporter	NULL
gene	NULL
was	NULL
9	NULL
to	NULL
13	NULL
times	NULL
more	NULL
active	NULL
than	NULL
dN-LUC	NULL
,	NULL
indicating	NULL
enhanced	NULL
NF-kB	NULL
activity	NULL
in	NULL
HTLV-I-infected	NULL
cell	NULL
lines	NULL
.	NULL

Among	NULL
five	NULL
HTLV	NULL
--	NULL
infected	NULL
cell	NULL
lines	NULL
,	NULL
four	NULL
(	NULL
MT-2	NULL
,	NULL
HUT-102	NULL
,	NULL
SLB-1	NULL
,	NULL
C5/MJ	NULL
)	NULL
expressed	NULL
high	NULL
levels	NULL
of	NULL
HTLV-I	NULL
Tax	NULL
transcript	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
TL-Om	NULL
!	NULL

1	NULL
cell	NULL
line	NULL
``	NULL
failed	NULL
to	NULL
express	NULL
significant	NULL
amounts	NULL
of	NULL
Tax	NULL
at	NULL
the	NULL
mRNA	NULL
level	NULL
(	NULL
Fig	NULL
1B	NULL
)	NULL
.	NULL

TL-Om	NULL
!	NULL

1	NULL
did	NULL
not	NULL
express	NULL
Tax	NULL
mRNA	NULL
at	NULL
all	NULL
by	NULL
a	NULL
highly	NULL
sensitive	NULL
polymerase	NULL
chain	NULL
reaction	NULL
method	NULL
coupled	NULL
with	NULL
reverse	NULL
tran-scription	NULL
.	NULL
``	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
Tax	NULL
is	NULL
not	NULL
required	NULL
to	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2362	NULL
k	NULL
B-LUC/dN-LUC	NULL
Bo	NULL
3	NULL
?	NULL

``	NULL
8	NULL
z	NULL
to	NULL
3	NULL
¥	NULL
hoof	NULL
oR	NULL
2	NULL
a	NULL
3	NULL
1	NULL
g	NULL
=	NULL
E	NULL
a	NULL
9	NULL
§	NULL
3	NULL
2	NULL
iI	NULL
L.	NULL
J	NULL
l	NULL
j	NULL
HTLV-I	NULL
(	NULL
-	NULL
)	NULL
HTLV-I	NULL
(	NULL
+	NULL
)	NULL
B	NULL
HTLV-I	NULL
(	NULL
=	NULL
)	NULL
_-	NULL
HTLV-I	NULL
(	NULL
+	NULL
)	NULL
o-oy	NULL
w	NULL
T	NULL
o	NULL
“	NULL
é	NULL
$	NULL
-	NULL
w	NULL
I	NULL
To	NULL
6	NULL
$	NULL
Low	NULL
®	NULL
a	NULL
i-	NULL
m	NULL
600	NULL
%	NULL
3	NULL
Q9	NULL
1	NULL
k	NULL
J	NULL
Jd	NULL
_	NULL
in	NULL
~	NULL
3	NULL
I	NULL
%	NULL
I	NULL
m	NULL
-	NULL
Q	NULL
tute	NULL
Tax	NULL
--	NULL
Fig	NULL
1	NULL
.	NULL

-	NULL
(	NULL
A	NULL
)	NULL
HTLV-l-infected	NULL
T-cell	NULL
lines	NULL
express	NULL
a	NULL
constitutive	NULL
NF-	NULL
«	NULL
B-related	NULL
activity	NULL
.	NULL

Various	NULL
cell	NULL
lines	NULL
were	NULL
transfected	NULL
with	NULL
10	NULL
pg	NULL
of	NULL
a	NULL
reporter	NULL
plasmid	NULL
containing	NULL
the	NULL
luciferase	NULL
gene	NULL
fused	NULL
to	NULL
five	NULL
repeats	NULL
of	NULL
the	NULL
«	NULL
B	NULL
motif	NULL
of	NULL
the	NULL
IL-2R	NULL
«	NULL
gene	NULL
and	NULL
enhancerless	NULL
promoter	NULL
of	NULL
HTLV-I	NULL
(	NULL
«	NULL
B-LUC	NULL
)	NULL
.	NULL

After	NULL
24	NULL
hours	NULL
of	NULL
incubation	NULL
,	NULL
lysates	NULL
were	NULL
prepared	NULL
and	NULL
assayed	NULL
for	NULL
luciferase	NULL
activity	NULL
.	NULL

Ratio	NULL
of	NULL
luciferase	NULL
activity	NULL
in	NULL
extracts	NULL
of	NULL
xB-LUC-transfected	NULL
cells	NULL
is	NULL
expressed	NULL
to	NULL
that	NULL
for	NULL
dN-LUC-transfected	NULL
cells	NULL
.	NULL

The	NULL
results	NULL
represent	NULL
the	NULL
mean	NULL
of	NULL
three	NULL
experi-ments	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Northern	NULL
blot	NULL
analysis	NULL
of	NULL
Tax	NULL
in	NULL
various	NULL
cell	NULL
lines	NULL
.	NULL

Total	NULL
RNA	NULL
(	NULL
20	NULL
pg	NULL
of	NULL
each	NULL
)	NULL
was	NULL
isolated	NULL
from	NULL
various	NULL
cell	NULL
lines	NULL
.	NULL

Jurkat	NULL
,	NULL
MOLT-4	NULL
,	NULL
and	NULL
H-9	NULL
are	NULL
HTLV-l-uninfected	NULL
T-cell	NULL
lines	NULL
.	NULL

MT-2	NULL
,	NULL
HUT-102	NULL
,	NULL
SLB-1	NULL
,	NULL
TL-Om1	NULL
,	NULL
and	NULL
C5/	NULL
M	NULL
J	NULL
are	NULL
HTLV	NULL
--	NULL
infected	NULL
T-cell	NULL
lines	NULL
.	NULL

Blots	NULL
were	NULL
sequentially	NULL
hybridized	NULL
,	NULL
exposed	NULL
,	NULL
stripped	NULL
,	NULL
and	NULL
rehybridized	NULL
with	NULL
Tax	NULL
and	NULL
GAPDH	NULL
probes	NULL
.	NULL

maintain	NULL
NE-kB-dependent	NULL
transcription	NULL
in	NULL
HTLV-l-infected	NULL
T-cell	NULL
lines	NULL
.	NULL

Potential	NULL
alterations	NULL
in	NULL
cellular	NULL
gene	NULL
activation	NULL
associated	NULL
with	NULL
the	NULL
Tax-independent	NULL
activation	NULL
of	NULL
NF-KB	NULL
in	NULL
TL-Om|1	NULL
were	NULL
next	NULL
studied	NULL
by	NULL
measuring	NULL
expression	NULL
of	NULL
the	NULL
IL-2Ra	NULL
protein	NULL
and	NULL
its	NULL
mRNA	NULL
.	NULL

Like	NULL
the	NULL
other	NULL
four	NULL
Tax-expressing	NULL
cell	NULL
lines	NULL
,	NULL
TL-Om	NULL
!	NULL

1	NULL
expressed	NULL
IL-2Ra	NULL
on	NULL
its	NULL
surface	NULL
(	NULL
Fig	NULL
2A	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
constitutive	NULL
expression	NULL
of	NULL
the	NULL
258	NULL
and	NULL
168	NULL
forms	NULL
of	NULL
IL-2R	NULL
«	NULL
MORI	NULL
ET	NULL
AL	NULL
mRNA	NULL
``	NULL
was	NULL
detected	NULL
in	NULL
TL-Om1	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
other	NULL
four	NULL
HTLV	NULL
--	NULL
infected	NULL
cell	NULL
lines	NULL
,	NULL
whereas	NULL
it	NULL
was	NULL
not	NULL
in	NULL
uninfected	NULL
cell	NULL
lines	NULL
(	NULL
Fig	NULL
2B	NULL
)	NULL
.	NULL

These	NULL
results	NULL
showed	NULL
that	NULL
TL-Om1	NULL
has	NULL
a	NULL
Tax-independent	NULL
constitutive	NULL
expression	NULL
of	NULL
the	NULL
IL-2Ra	NULL
gene	NULL
,	NULL
possibly	NULL
due	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Lower	NULL
protein	NULL
levels	NULL
of	NULL
IxBa	NULL
in	NULL
HTLV	NULL
--	NULL
infected	NULL
T-cell	NULL
lines	NULL
.	NULL

In	NULL
a	NULL
variety	NULL
of	NULL
cell	NULL
lines	NULL
,	NULL
NF-KB	NULL
is	NULL
localized	NULL
in	NULL
the	NULL
cytoplasm	NULL
through	NULL
binding	NULL
to	NULL
specific	NULL
cytoplasmic	NULL
molecules	NULL
called	NULL
IxBa	NULL
.	NULL

After	NULL
cellular	NULL
stimulation	NULL
by	NULL
multiple	NULL
inducers	NULL
,	NULL
activation	NULL
of	NULL
signal	NULL
transduction	NULL
cascades	NULL
leads	NULL
to	NULL
the	NULL
degradation	NULL
of	NULL
IxBa	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
prior	NULL
studies	NULL
,	NULL
``	NULL
``	NULL
the	NULL
protein	NULL
level	NULL
of	NULL
IxBa	NULL
was	NULL
significantly	NULL
lower	NULL
in	NULL
HTLV-I-infected	NULL
cell	NULL
lines	NULL
(	NULL
Fig	NULL
3A	NULL
)	NULL
.	NULL

More	NULL
importantly	NULL
,	NULL
TL-Om1	NULL
cells	NULL
,	NULL
which	NULL
do	NULL
not	NULL
express	NULL
Tax	NULL
,	NULL
have	NULL
reduced	NULL
IxBa	NULL
protein	NULL
at	NULL
a	NULL
similar	NULL
level	NULL
to	NULL
HTLV-I-infected	NULL
cell	NULL
lines	NULL
expressing	NULL
Tax	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
IxBa	NULL
protein	NULL
expression	NULL
is	NULL
downregulated	NULL
in	NULL
TL-Om1	NULL
by	NULL
a	NULL
Tax-independent	NULL
mechanism	NULL
.	NULL

A	NULL
125	NULL
)	NULL
3	NULL
o	NULL
75	NULL
50	NULL
IL-2R	NULL
a	NULL
-positive	NULL
cells	NULL
(	NULL
%	NULL
25	NULL
#	NULL
0	NULL
f	NULL
2	NULL
#	NULL
§	NULL
po	NULL
fg	NULL
3	NULL
50g	NULL
°o	NULL
E	NULL
Po	NULL
@	NULL
9	NULL
8	NULL
3	NULL
2	NULL
fw	NULL
T	NULL
L	NULL
J	NULL
1	NULL
I	NULL
HTLV	NULL
(	NULL
-	NULL
)	NULL
HTLV-I	NULL
(	NULL
+	NULL
)	NULL
B	NULL
HTLV-1	NULL
(	NULL
-	NULL
)	NULL
_	NULL
HTLV-I	NULL
(	NULL
+	NULL
)	NULL
J	NULL
J	NULL
OU	NULL
o	NULL
0	NULL
=	NULL
$	NULL
k	NULL
2	NULL
a	NULL
T	NULL
T	NULL
6	NULL
3	NULL
ism	NULL
.	NULL

»	NULL
—m.\	NULL
3	NULL
bok	NULL
2	NULL
_J	NULL
J	NULL
i	NULL
~	NULL
3	NULL
I	NULL
5	NULL
I	NULL
wm	NULL
i-	NULL
Uo	NULL
a	NULL
=	NULL
IL-	NULL
2R	NULL
a	NULL
<	NULL
-	NULL
>	NULL
Fig	NULL
2	NULL
.	NULL

Expression	NULL
of	NULL
IL-2Re	NULL
«	NULL
at	NULL
protein	NULL
(	NULL
A	NULL
)	NULL
and	NULL
mRNA	NULL
(	NULL
B	NULL
)	NULL
levels	NULL
in	NULL
various	NULL
cell	NULL
lines	NULL
.	NULL

(	NULL
A	NULL
)	NULL
The	NULL
percentages	NULL
of	NULL
positive	NULL
cells	NULL
for	NULL
IL-2R	NULL
«	NULL
are	NULL
shown	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Total	NULL
RNA	NULL
(	NULL
20	NULL
pg	NULL
of	NULL
each	NULL
)	NULL
was	NULL
isolated	NULL
from	NULL
various	NULL
cell	NULL
lines	NULL
and	NULL
assessed	NULL
for	NULL
IL-2R	NULL
«	NULL
or	NULL
GAPDH	NULL
mRNA	NULL
expression	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

NF-kB	NULL
ACTIVATION	NULL
IN	NULL
ATL	NULL
A	NULL
O	NULL
a	NULL
<	NULL
O	NULL
E	NULL
s	NULL
!	NULL

-	NULL
-	NULL
=	NULL
$	NULL
q	NULL
s	NULL
ps	NULL
i	NULL
6	NULL
f	NULL
~	NULL
p3	NULL
e	NULL
a	NULL
E	NULL
U	NULL
p21	NULL
8	NULL
|	NULL
xB	NULL
a	NULL
-p	NULL
|	NULL
<	NULL
p	NULL
m-1	NULL
-	NULL
2	NULL
3	NULL
-	NULL
4	NULL
50	NULL
6	NULL
7	NULL
-	NULL
8	NULL
L.	NULL
JL_	NULL
J	NULL
HTLV-I	NULL
(	NULL
-	NULL
)	NULL
HTLV-I	NULL
(	NULL
+	NULL
)	NULL
B	NULL
HTLV-I	NULL
(	NULL
-	NULL
)	NULL
HTLV-I	NULL
(	NULL
+	NULL
)	NULL
I	NULL
1	NULL
|	NULL
4	NULL
<	NULL
8	NULL
_	NULL
=	NULL
§	NULL
K	NULL
Qa	NULL
o	NULL
T	NULL
67	NULL
x	NULL
a	NULL
®	NULL
E	NULL
m	NULL
2	NULL
<	NULL
33	NULL
no	NULL
f-	NULL
2	NULL
_	NULL
_	NULL
ou	NULL
~	NULL
3	NULL
IT	NULL
3	NULL
T	NULL
i	NULL
-	NULL
G	NULL
|	NULL
kB	NULL
a	NULL
m	NULL
“	NULL
.	NULL

..-	NULL
.	NULL

Fig	NULL
3	NULL
.	NULL

Expression	NULL
of	NULL
IkBa	NULL
at	NULL
protein	NULL
(	NULL
A	NULL
)	NULL
and	NULL
mRNA	NULL
(	NULL
B	NULL
)	NULL
levels	NULL
in	NULL
various	NULL
cell	NULL
lines	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Whole-cell	NULL
extracts	NULL
were	NULL
isolated	NULL
from	NULL
the	NULL
cells	NULL
and	NULL
analyzed	NULL
by	NULL
Western	NULL
blotting	NULL
using	NULL
anti-lkBe	NULL
antibody	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Total	NULL
RNA	NULL
(	NULL
20	NULL
g	NULL
of	NULL
each	NULL
)	NULL
was	NULL
isolated	NULL
from	NULL
various	NULL
cell	NULL
lines	NULL
and	NULL
assessed	NULL
for	NULL
IkBa	NULL
or	NULL
GAPDH	NULL
mRNA	NULL
expression	NULL
.	NULL

Overexpression	NULL
of	NULL
IxBa	NULL
mRNA	NULL
in	NULL
HTLV-L-infected	NULL
T-cell	NULL
lines	NULL
.	NULL

Next	NULL
,	NULL
we	NULL
performed	NULL
Northern	NULL
blot	NULL
analysis	NULL
of	NULL
IxBa	NULL
mRNA	NULL
in	NULL
the	NULL
T-cell	NULL
lines	NULL
characterized	NULL
above	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
3B	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
IxBa	NULL
mRNA	NULL
in	NULL
TL-Om1	NULL
,	NULL
as	NULL
well	NULL
as	NULL
Tax-expressing	NULL
cell	NULL
lines	NULL
,	NULL
was	NULL
strikingly	NULL
higher	NULL
than	NULL
in	NULL
uninfected	NULL
ones	NULL
.	NULL

Thus	NULL
,	NULL
decreased	NULL
IxBa	NULL
protein	NULL
level	NULL
detected	NULL
in	NULL
HTLV-L-infected	NULL
cell	NULL
lines	NULL
,	NULL
including	NULL
TL-Om	NULL
!	NULL

1	NULL
,	NULL
is	NULL
not	NULL
due	NULL
to	NULL
impaired	NULL
IxBa	NULL
gene	NULL
activity	NULL
,	NULL
but	NULL
due	NULL
to	NULL
the	NULL
rapid	NULL
turnover	NULL
of	NULL
IxBa	NULL
.	NULL

It	NULL
has	NULL
been	NULL
reported	NULL
previously	NULL
that	NULL
Tax	NULL
disrupts	NULL
feedback	NULL
regulation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
through	NULL
destabilization	NULL
of	NULL
thus	NULL
establishing	NULL
constitutive	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

JPX-9	NULL
cells	NULL
are	NULL
derived	NULL
from	NULL
a	NULL
human	NULL
T-cell	NULL
line	NULL
Jurkat	NULL
,	NULL
and	NULL
they	NULL
are	NULL
permanently	NULL
transfected	NULL
with	NULL
a	NULL
metallothionein	NULL
promoter-driven	NULL
Tax	NULL
expression	NULL
vector	NULL
.	NULL
``	NULL

''	NULL
As	NULL
a	NULL
result	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
Tax	NULL
in	NULL
JPX-9	NULL
cells	NULL
by	NULL
CdC	NULL
]	NULL
;	NULL
treatment	NULL
,	NULL
IxBa	NULL
mRNA	NULL
expression	NULL
was	NULL
markedly	NULL
upregulated	NULL
(	NULL
Fig	NULL
4A	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
total	NULL
protein	NULL
2363	NULL
levels	NULL
for	NULL
IxBa	NULL
remained	NULL
constant	NULL
(	NULL
Fig	NULL
4B	NULL
)	NULL
,	NULL
possibly	NULL
indicative	NULL
of	NULL
a	NULL
more	NULL
rapid	NULL
turnover	NULL
of	NULL
IxBa	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
show	NULL
that	NULL
Tax-mediated	NULL
destabilization	NULL
of	NULL
IxBa	NULL
is	NULL
the	NULL
mechanism	NULL
for	NULL
reduction	NULL
of	NULL
IxBa	NULL
protein	NULL
in	NULL
HTLV-I-infected	NULL
cell	NULL
lines	NULL
expressing	NULL
Tax	NULL
.	NULL

These	NULL
data	NULL
also	NULL
suggest	NULL
that	NULL
rapid	NULL
degradation	NULL
of	NULL
IxBa	NULL
is	NULL
maintained	NULL
by	NULL
mechanisms	NULL
other	NULL
than	NULL
Tax	NULL
in	NULL
TL-Om	NULL
!	NULL

1	NULL
cells	NULL
.	NULL

Enhanced	NULL
IxBa	NULL
degradation	NULL
in	NULL
primary	NULL
ATL	NULL
cells	NULL
.	NULL

We	NULL
had	NULL
postulated	NULL
that	NULL
the	NULL
IxBa	NULL
«	NULL
/NF-	NULL
«	NULL
B	NULL
pathways	NULL
may	NULL
already	NULL
be	NULL
activated	NULL
in	NULL
ATL	NULL
leukemic	NULL
cells	NULL
in	NULL
vivo	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
examined	NULL
whether	NULL
the	NULL
expression	NULL
of	NULL
IxBa	NULL
in	NULL
freshly	NULL
obtained	NULL
PBMC	NULL
of	NULL
ATL	NULL
patients	NULL
is	NULL
upregulated	NULL
.	NULL

PBMC	NULL
were	NULL
isolated	NULL
from	NULL
peripheral	NULL
blood	NULL
of	NULL
seven	NULL
ATL	NULL
patients	NULL
and	NULL
RNA	NULL
was	NULL
prepared	NULL
for	NULL
Northern	NULL
blot	NULL
analysis	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
5A	NULL
,	NULL
IxBa	NULL
mRNA	NULL
A	NULL
Time	NULL
(	NULL
h	NULL
)	NULL
O	NULL
_	NULL
2	NULL
5	NULL
10	NULL
24	NULL
48	NULL
72	NULL
Tax	NULL
|	NULL
kB	NULL
a	NULL
Time	NULL
(	NULL
h	NULL
)	NULL
0	NULL
5	NULL
10	NULL
_	NULL
24	NULL
-	NULL
48	NULL
72	NULL
|	NULL
<	NULL
B	NULL
a	NULL
-im	NULL
«	NULL
o	NULL
«	NULL
o	NULL
_	NULL
«	NULL
ib	NULL
swam	NULL
.	NULL

.	NULL

allt	NULL
Fig	NULL
4	NULL
.	NULL

Tax-induced	NULL
proteolytic	NULL
degradation	NULL
of	NULL
IkBa	NULL
.	NULL

JPX-9	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
CdCI	NULL
;	NULL
(	NULL
20	NULL
pmol/L	NULL
)	NULL
for	NULL
the	NULL
indicated	NULL
time	NULL
periods	NULL
and	NULL
then	NULL
collected	NULL
for	NULL
preparation	NULL
of	NULL
either	NULL
total	NULL
cellular	NULL
RNA	NULL
or	NULL
whole-cell	NULL
extracts	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Total	NULL
RNA	NULL
isolated	NULL
from	NULL
either	NULL
nontreated	NULL
or	NULL
CdCi	NULL
,	NULL
-treated	NULL
JPX-9	NULL
cells	NULL
was	NULL
subjected	NULL
to	NULL
Northern	NULL
blot	NULL
analysis	NULL
with	NULL
Tax	NULL
,	NULL
IkBa	NULL
,	NULL
and	NULL
GAPDH	NULL
probes	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Whole-cell	NULL
extracts	NULL
isolated	NULL
from	NULL
CdCi	NULL
,	NULL
-treated	NULL
JPX-9	NULL
cells	NULL
were	NULL
subjected	NULL
to	NULL
Western	NULL
blotting	NULL
using	NULL
anti-lkBe	NULL
antibody	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2364	NULL
|	NULL
kB	NULL
a	NULL
©	NULL
@	NULL
eegu=e	NULL
!	NULL

IL-	NULL
2R	NULL
a	NULL
``	NULL
‘	NULL
..	NULL
'	NULL
GAPDH	NULL
|	NULL
B	NULL
Co	NULL
al	NULL
arora	NULL
?	NULL

aP	NULL
al	NULL
CEG	NULL
T	NULL
F	NULL
p	NULL
``	NULL
p	NULL
``	NULL
p	NULL
|	NULL
xB	NULL
a	NULL
--	NULL
i	NULL
amo	NULL
Gap	NULL
Gap	NULL
ca	NULL
»	NULL
as	NULL
cammy	NULL
Fig	NULL
5	NULL
.	NULL

Expression	NULL
of	NULL
IkBa	NULL
«	NULL
at	NULL
mRNA	NULL
(	NULL
A	NULL
)	NULL
and	NULL
protein	NULL
(	NULL
B	NULL
)	NULL
levels	NULL
in	NULL
primary	NULL
leukemic	NULL
cells	NULL
from	NULL
ATL	NULL
patients	NULL
and	NULL
normal	NULL
healthy	NULL
subjects	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Total	NULL
RNA	NULL
was	NULL
extracted	NULL
from	NULL
PBMC	NULL
and	NULL
assessed	NULL
for	NULL
IkBa	NULL
,	NULL
IL-2R	NULL
«	NULL
,	NULL
or	NULL
GAPDH	NULL
mRNA	NULL
expression	NULL
.	NULL

A	NULL
representative	NULL
Northern	NULL
blot	NULL
is	NULL
shown	NULL
from	NULL
patients	NULL
with	NULL
ATL	NULL
and	NULL
healthy	NULL
subjects	NULL
(	NULL
normal	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
PBMC	NULL
obtained	NULL
from	NULL
patients	NULL
with	NULL
ATL	NULL
or	NULL
healthy	NULL
subjects	NULL
(	NULL
normal	NULL
)	NULL
were	NULL
assessed	NULL
for	NULL
IkBa	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
.	NULL

levels	NULL
in	NULL
freshly	NULL
isolated	NULL
PBMC	NULL
of	NULL
ATL	NULL
patients	NULL
were	NULL
much	NULL
higher	NULL
than	NULL
those	NULL
in	NULL
PBMC	NULL
from	NULL
healthy	NULL
control	NULL
subjects	NULL
.	NULL

Furthermore	NULL
,	NULL
IL-2Ra	NULL
expression	NULL
was	NULL
stronger	NULL
in	NULL
primary	NULL
ATL	NULL
cells	NULL
than	NULL
in	NULL
normal	NULL
PBMC	NULL
(	NULL
Fig	NULL
5A	NULL
)	NULL
.	NULL

These	NULL
results	NULL
are	NULL
similar	NULL
to	NULL
the	NULL
high	NULL
expression	NULL
of	NULL
IxBa	NULL
and	NULL
IL-2Ra	NULL
mRNA	NULL
observed	NULL
in	NULL
HTLV	NULL
--	NULL
infected	NULL
T-cell	NULL
lines	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
Tax	NULL
expression	NULL
in	NULL
the	NULL
primary	NULL
cells	NULL
isolated	NULL
from	NULL
these	NULL
patients	NULL
was	NULL
hard	NULL
to	NULL
estimate	NULL
quantitatively	NULL
with	NULL
Northern	NULL
and	NULL
Western	NULL
blot	NULL
analyses	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
next	NULL
determined	NULL
the	NULL
protein	NULL
levels	NULL
of	NULL
IxBa	NULL
in	NULL
blood	NULL
mononuclear	NULL
cells	NULL
from	NULL
patients	NULL
with	NULL
ATL	NULL
and	NULL
from	NULL
healthy	NULL
subjects	NULL
.	NULL

Whole-cell	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
PBMC	NULL
and	NULL
subjected	NULL
to	NULL
Western	NULL
blot	NULL
analysis	NULL
(	NULL
Fig	NULL
5B	NULL
)	NULL
.	NULL

The	NULL
IxBa	NULL
reactivity	NULL
band	NULL
was	NULL
strongly	NULL
visible	NULL
in	NULL
PBMC	NULL
from	NULL
healthy	NULL
subjects	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
IxBa	NULL
reactivity	NULL
was	NULL
weak	NULL
in	NULL
PBMC	NULL
derived	NULL
from	NULL
two	NULL
cases	NULL
(	NULL
ATL	NULL
patients	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

The	NULL
remaining	NULL
five	NULL
samples	NULL
did	NULL
not	NULL
show	NULL
apparent	NULL
reduction	NULL
of	NULL
the	NULL
bands	NULL
.	NULL

However	NULL
,	NULL
these	NULL
results	NULL
were	NULL
not	NULL
influenced	NULL
by	NULL
the	NULL
contents	NULL
of	NULL
leukemic	NULL
cells	NULL
in	NULL
MORI	NULL
ET	NULL
AL	NULL
these	NULL
samples	NULL
.	NULL

While	NULL
IxBa	NULL
mRNA	NULL
levels	NULL
were	NULL
dramatically	NULL
upregulated	NULL
in	NULL
ATL	NULL
cells	NULL
,	NULL
the	NULL
total	NULL
protein	NULL
levels	NULL
did	NULL
not	NULL
increase	NULL
,	NULL
possibly	NULL
indicative	NULL
of	NULL
protein	NULL
degradation	NULL
.	NULL

Constitutive	NULL
NF-xB	NULL
binding	NULL
activity	NULL
in	NULL
HTLV	NULL
--	NULL
infected	NULL
T-cell	NULL
lines	NULL
and	NULL
primary	NULL
ATL	NULL
cells	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
degradation	NULL
of	NULL
IxBa	NULL
protein	NULL
in	NULL
HTLV-l-infected	NULL
T-cell	NULL
lines	NULL
was	NULL
associated	NULL
with	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
,	NULL
nuclear	NULL
extracts	NULL
of	NULL
cells	NULL
were	NULL
subjected	NULL
to	NULL
EMSA	NULL
.	NULL

In	NULL
uninfected	NULL
T-cell	NULL
lines	NULL
,	NULL
no	NULL
NF-kB	NULL
specific	NULL
protein	NULL
DNA	NULL
complexes	NULL
were	NULL
detected	NULL
in	NULL
nuclear	NULL
extracts	NULL
by	NULL
EMSA	NULL
(	NULL
Fig	NULL
6A	NULL
,	NULL
lanes	NULL
1	NULL
through	NULL
3	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
enhanced	NULL
NF-KB	NULL
activity	NULL
was	NULL
present	NULL
in	NULL
each	NULL
of	NULL
the	NULL
HTLV	NULL
--	NULL
infected	NULL
T-cell	NULL
lines	NULL
tested	NULL
(	NULL
Fig	NULL
6A	NULL
,	NULL
lanes	NULL
4	NULL
through	NULL
8	NULL
)	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
the	NULL
binding	NULL
activities	NULL
was	NULL
shown	NULL
by	NULL
competition	NULL
with	NULL
excess	NULL
wild-type	NULL
and	NULL
mutant	NULL
oligonucleotides	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Constitutive	NULL
NF-kB	NULL
binding	NULL
activity	NULL
in	NULL
MT-2	NULL
cells	NULL
was	NULL
composed	NULL
predominantly	NULL
of	NULL
c-Rel	NULL
and	NULL
p50	NULL
,	NULL
as	NULL
antibodies	NULL
against	NULL
c-Rel	NULL
and	NULL
p50	NULL
partially	NULL
inhibited	NULL
formation	NULL
of	NULL
the	NULL
DNA	NULL
complex	NULL
and	NULL
also	NULL
produced	NULL
a	NULL
shifted	NULL
complex	NULL
(	NULL
Fig	NULL
6B	NULL
,	NULL
left	NULL
panel	NULL
)	NULL
.	NULL

Similar	NULL
analyses	NULL
showed	NULL
that	NULL
c-Rel	NULL
and	NULL
p50	NULL
subunits	NULL
represented	NULL
the	NULL
main	NULL
DNA	NULL
binding	NULL
components	NULL
in	NULL
HUT-102	NULL
,	NULL
SLB-1	NULL
,	NULL
and	NULL
C5/MJ	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
TL-Om	NULL
!	NULL

1	NULL
cells	NULL
,	NULL
two	NULL
forms	NULL
of	NULL
complexes	NULL
were	NULL
detected	NULL
(	NULL
Fig	NULL
6A	NULL
)	NULL
.	NULL

Incubation	NULL
of	NULL
the	NULL
nuclear	NULL
extracts	NULL
with	NULL
various	NULL
antibodies	NULL
represented	NULL
that	NULL
the	NULL
upper	NULL
band	NULL
contains	NULL
p50	NULL
and	NULL
p65	NULL
,	NULL
and	NULL
the	NULL
lower	NULL
band	NULL
contains	NULL
only	NULL
the	NULL
p50	NULL
(	NULL
Fig	NULL
6B	NULL
,	NULL
right	NULL
panel	NULL
)	NULL
.	NULL

We	NULL
determined	NULL
whether	NULL
degradation	NULL
of	NULL
IKBa	NULL
protein	NULL
in	NULL
primary	NULL
ATL	NULL
cells	NULL
involved	NULL
abnormal	NULL
NF-	NULL
«	NULL
kB-specific	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

To	NULL
address	NULL
this	NULL
question	NULL
,	NULL
nuclear	NULL
extracts	NULL
of	NULL
PBMC	NULL
obtained	NULL
from	NULL
seven	NULL
patients	NULL
with	NULL
ATL	NULL
and	NULL
healthy	NULL
subjects	NULL
,	NULL
the	NULL
same	NULL
samples	NULL
as	NULL
analyzed	NULL
in	NULL
Fig	NULL
5	NULL
,	NULL
were	NULL
subjected	NULL
A	NULL
C	NULL
9	NULL
iq	NULL
)	NULL
.	NULL

5	NULL
$	NULL
a	NULL
W	NULL
a	NULL
``	NULL
ata	NULL
(	NULL
o	NULL
1	NULL
2	NULL
3	NULL
4	NULL
L	NULL
I1	NULL
B	NULL
HTLV-I	NULL
(	NULL
-	NULL
)	NULL
0	NULL
p	NULL
°	NULL
Antibody	NULL
:	NULL
-	NULL
Q6	NULL
)	NULL
Q6	NULL
Q	NULL
'	NULL
Q	NULL
Q	NULL
<	NULL
9	NULL
-	NULL
|W	NULL
UW	NULL
HW	NULL
MT-	NULL
2	NULL
5060	NULL
7	NULL
8s	NULL
,	NULL
HTLV-I	NULL
(	NULL
+	NULL
)	NULL
08Q3	NULL
>	NULL
fb	NULL
_	NULL
8	NULL
N	NULL
2	NULL
Ill	NULL
-a-	NULL
TL-	NULL
Om1	NULL
Fig	NULL
6	NULL
.	NULL

NF-B	NULL
binding	NULL
activity	NULL
in	NULL
various	NULL
cell	NULL
lines	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
cells	NULL
.	NULL

Nuclear	NULL
extracts	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
[	NULL
°°P	NULL
]	NULL
-radiolabeled	NULL
oligonucleotide	NULL
that	NULL
corresponds	NULL
to	NULL
the	NULL
B	NULL
sequence	NULL
of	NULL
the	NULL
IL-2Re	NULL
gene	NULL
and	NULL
analyzed	NULL
by	NULL
EMSA	NULL
.	NULL

(	NULL
B	NULL
)	NULL
In	NULL
super-shift	NULL
assays	NULL
,	NULL
antibody	NULL
specific	NULL
for	NULL
each	NULL
NF-xB	NULL
subunit	NULL
(	NULL
indicated	NULL
above	NULL
the	NULL
lanes	NULL
)	NULL
was	NULL
incubated	NULL
with	NULL
MT-2	NULL
and	NULL
TL-Om1	NULL
extracts	NULL
before	NULL
probe	NULL
addition	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
ACTIVATION	NULL
IN	NULL
ATL	NULL
G	NULL
A	NULL
¢	NULL
``	NULL
¥	NULL
?	NULL

aa	NULL
aP	NULL
a	NULL
B	NULL
--	NULL
|b	NULL
bo	NULL
04	NULL
b4	NULL
4	NULL
64	NULL
66	NULL
04	NULL
Competitor	NULL
:	NULL
-p	NULL
-m	NULL
D	NULL
ATL3	NULL
>	NULL
®	NULL
p	NULL
®	NULL
2	NULL
Antibody	NULL
:	NULL
-	NULL
®	NULL
Q	NULL
‘	NULL
c	NULL
&	NULL
QC	NULL
)	NULL
44	NULL
¥	NULL
]	NULL
-¥	NULL
”	NULL
HH	NULL
’	NULL
N	NULL
,	NULL
HHH	NULL
J_	NULL
i	NULL
i	NULL
ATL3	NULL
Nor	NULL
mal	NULL
A	NULL
0	NULL
.8	NULL
<	NULL
``	NULL
2	NULL
Q	NULL
‘	NULL
s	NULL
9b	NULL
a	NULL
Q	NULL
‘	NULL
s	NULL
Fig	NULL
7	NULL
.	NULL

Activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
primary	NULL
ATL	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Nuclear	NULL
extracts	NULL
(	NULL
5	NULL
pg	NULL
)	NULL
from	NULL
PBMC	NULL
from	NULL
patients	NULL
with	NULL
ATL	NULL
or	NULL
from	NULL
healthy	NULL
subjects	NULL
(	NULL
normal	NULL
)	NULL
were	NULL
assessed	NULL
for	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
EMSA	NULL
.	NULL

The	NULL
right	NULL
panel	NULL
represents	NULL
a	NULL
lighter	NULL
exposure	NULL
of	NULL
patients	NULL
2	NULL
,	NULL
5	NULL
,	NULL
6	NULL
,	NULL
and	NULL
7	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Nuclear	NULL
extracts	NULL
from	NULL
patients	NULL
with	NULL
ATL	NULL
or	NULL
from	NULL
healthy	NULL
subjects	NULL
(	NULL
normal	NULL
)	NULL
were	NULL
analyzed	NULL
for	NULL
protein	NULL
binding	NULL
to	NULL
the	NULL
octamer	NULL
consensus	NULL
sequence	NULL
by	NULL
EMSA	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Nuclear	NULL
extracts	NULL
from	NULL
patient	NULL
3	NULL
sample	NULL
were	NULL
coincubated	NULL
with	NULL
100-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
oligonucleotides	NULL
and	NULL
assessed	NULL
in	NULL
parallel	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Nuclear	NULL
extracts	NULL
were	NULL
preincubated	NULL
with	NULL
NF-B	NULL
subunit-specific	NULL
antibody	NULL
,	NULL
as	NULL
indicated	NULL
above	NULL
each	NULL
lane	NULL
,	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
radiolabeled	NULL
probe	NULL
(	NULL
as	NULL
in	NULL
Fig	NULL
6	NULL
)	NULL
.	NULL

to	NULL
EMSA	NULL
.	NULL

In	NULL
extracts	NULL
from	NULL
healthy	NULL
subjects	NULL
,	NULL
complex	NULL
was	NULL
detected	NULL
(	NULL
Fig	NULL
7A	NULL
,	NULL
left	NULL
panel	NULL
)	NULL
.	NULL

This	NULL
protein	NULL
DNA	NULL
complex	NULL
was	NULL
composed	NULL
primarily	NULL
of	NULL
p50	NULL
;	NULL
interaction	NULL
with	NULL
anti-p65	NULL
,	NULL
c-Rel	NULL
,	NULL
and	NULL
p52	NULL
antibodies	NULL
was	NULL
negligible	NULL
(	NULL
Fig	NULL
7D	NULL
,	NULL
right	NULL
panel	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
two	NULL
forms	NULL
of	NULL
complexes	NULL
were	NULL
detected	NULL
,	NULL
an	NULL
upper	NULL
band	NULL
and	NULL
a	NULL
lower	NULL
band	NULL
in	NULL
extracts	NULL
from	NULL
primary	NULL
ATL	NULL
cells	NULL
(	NULL
Fig	NULL
7A	NULL
,	NULL
left	NULL
panel	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
observed	NULL
complexes	NULL
formed	NULL
broad	NULL
bands	NULL
in	NULL
patients	NULL
2	NULL
,	NULL
5	NULL
,	NULL
6	NULL
,	NULL
and	NULL
7	NULL
,	NULL
lighter	NULL
exposure	NULL
of	NULL
the	NULL
gel	NULL
showed	NULL
two	NULL
bands	NULL
in	NULL
these	NULL
cases	NULL
(	NULL
Fig	NULL
7A	NULL
,	NULL
right	NULL
panel	NULL
)	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
these	NULL
complexes	NULL
was	NULL
verified	NULL
by	NULL
competition	NULL
with	NULL
an	NULL
excess	NULL
of	NULL
wild-type	NULL
and	NULL
mutant	NULL
oligonucleotides	NULL
(	NULL
Fig	NULL
7C	NULL
)	NULL
.	NULL

Incubation	NULL
of	NULL
the	NULL
protein	NULL
DNA	NULL
complex	NULL
with	NULL
anti-p50	NULL
resulted	NULL
in	NULL
almost	NULL
complete	NULL
supershift	NULL
of	NULL
the	NULL
upper	NULL
and	NULL
lower	NULL
migrating	NULL
bands	NULL
(	NULL
Fig	NULL
7D	NULL
,	NULL
left	NULL
panel	NULL
)	NULL
.	NULL

Incubation	NULL
with	NULL
anti-p65	NULL
reduced	NULL
only	NULL
the	NULL
upper	NULL
band	NULL
completely	NULL
.	NULL

Further	NULL
,	NULL
anti-c-Rel	NULL
and	NULL
p52	NULL
antibodies	NULL
failed	NULL
to	NULL
shift	NULL
any	NULL
bands	NULL
(	NULL
Fig	NULL
7D	NULL
,	NULL
2365	NULL
left	NULL
panel	NULL
)	NULL
.	NULL

This	NULL
result	NULL
suggests	NULL
that	NULL
the	NULL
upper	NULL
band	NULL
contains	NULL
p50	NULL
and	NULL
p65	NULL
,	NULL
and	NULL
the	NULL
lower	NULL
band	NULL
contains	NULL
the	NULL
p50	NULL
homodimers	NULL
.	NULL

No	NULL
differences	NULL
between	NULL
ATL	NULL
patients	NULL
and	NULL
healthy	NULL
subjects	NULL
in	NULL
binding	NULL
to	NULL
the	NULL
octamer	NULL
motif	NULL
on	NULL
DNA	NULL
were	NULL
found	NULL
(	NULL
Fig	NULL
7B	NULL
)	NULL
.	NULL

Transactivational	NULL
activities	NULL
of	NULL
different	NULL
members	NULL
of	NULL
the	NULL
family	NULL
at	NULL
the	NULL
IL-2Ra	NULL
kB	NULL
site	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
transcription	NULL
activity	NULL
of	NULL
different	NULL
subunit	NULL
members	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

family	NULL
,	NULL
expression	NULL
plasmids	NULL
for	NULL
three	NULL
kB-related	NULL
proteins	NULL
,	NULL
p50	NULL
,	NULL
p65	NULL
,	NULL
and	NULL
c-Rel	NULL
,	NULL
were	NULL
cotransfected	NULL
in	NULL
Jurkat	NULL
cells	NULL
with	NULL
a	NULL
reporter	NULL
plasmid	NULL
,	NULL
kB-LUC	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
8	NULL
,	NULL
expression	NULL
of	NULL
p65	NULL
and	NULL
c-Rel	NULL
,	NULL
by	NULL
themselves	NULL
or	NULL
in	NULL
combination	NULL
with	NULL
p50	NULL
,	NULL
led	NULL
to	NULL
an	NULL
increase	NULL
in	NULL
luciferase	NULL
activity	NULL
,	NULL
while	NULL
expression	NULL
of	NULL
p50	NULL
was	NULL
devoid	NULL
of	NULL
effect	NULL
on	NULL
the	NULL
reporter	NULL
gene	NULL
transcription	NULL
.	NULL

These	NULL
results	NULL
recapitulate	NULL
the	NULL
observed	NULL
EMSA	NULL
and	NULL
IL-2Ra	NULL
«	NULL
expression	NULL
data	NULL
,	NULL
indicating	NULL
that	NULL
p65	NULL
or	NULL
c-Rel	NULL
binding	NULL
can	NULL
activate	NULL
NF-	NULL
«	NULL
kB-dependent	NULL
transcription	NULL
.	NULL

However	NULL
,	NULL
p50	NULL
homodimers	NULL
can	NULL
bind	NULL
to	NULL
the	NULL
kB	NULL
element	NULL
in	NULL
the	NULL
IL-2Ra	NULL
,	NULL
but	NULL
are	NULL
unable	NULL
to	NULL
support	NULL
transcriptional	NULL
activation	NULL
.	NULL

DISCUSSION	NULL
We	NULL
analyzed	NULL
for	NULL
the	NULL
first	NULL
time	NULL
the	NULL
functional	NULL
status	NULL
of	NULL
the	NULL
pathway	NULL
in	NULL
primary	NULL
leukemic	NULL
cells	NULL
from	NULL
ATL	NULL
patients	NULL
.	NULL

In	NULL
all	NULL
patients	NULL
,	NULL
protein	NULL
's	NULL
DNA	NULL
binding	NULL
activity	NULL
was	NULL
detected	NULL
by	NULL
EMSA	NULL
in	NULL
the	NULL
leukemic	NULL
cell	NULL
extracts	NULL
.	NULL

Furthermore	NULL
,	NULL
this	NULL
study	NULL
shows	NULL
that	NULL
in	NULL
contrast	NULL
to	NULL
healthy	NULL
subjects	NULL
,	NULL
IxBa	NULL
in	NULL
freshly	NULL
isolated	NULL
leukemic	NULL
cells	NULL
from	NULL
patients	NULL
with	NULL
ATL	NULL
has	NULL
600	NULL
500	NULL
400	NULL
300	NULL
200	NULL
LUC	NULL
activity	NULL
(	NULL
fold	NULL
activation	NULL
)	NULL
100	NULL
0	NULL
p50	NULL
-	NULL
+	NULL
-	NULL
-	NULL
+	NULL
+	NULL
p65	NULL
-	NULL
-	NULL
+	NULL
-	NULL
+	NULL
c-Rel	NULL
-	NULL
-	NULL
-	NULL
+	NULL
-	NULL
+	NULL
Fig	NULL
8	NULL
.	NULL

Effect	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
subunit	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
transcriptional	NULL
activity	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
electroporation	NULL
with	NULL
a	NULL
reporter	NULL
plasmid	NULL
(	NULL
5	NULL
pg	NULL
)	NULL
containing	NULL
the	NULL
luciferase	NULL
gene	NULL
fused	NULL
to	NULL
five	NULL
repeats	NULL
of	NULL
the	NULL
«	NULL
B	NULL
motif	NULL
of	NULL
the	NULL
IL-2R	NULL
«	NULL
gene	NULL
and	NULL
enhancerless	NULL
promoter	NULL
of	NULL
HTLV-I	NULL
(	NULL
B-LUC	NULL
)	NULL
along	NULL
with	NULL
combinations	NULL
of	NULL
the	NULL
cDNA	NULL
expression	NULL
plasmids	NULL
encoding	NULL
p50	NULL
(	NULL
5	NULL
pg	NULL
)	NULL
,	NULL
p65	NULL
(	NULL
5	NULL
mug	NULL
)	NULL
,	NULL
and	NULL
c-Rel	NULL
(	NULL
5	NULL
mg	NULL
)	NULL
indicated	NULL
at	NULL
the	NULL
bottom	NULL
of	NULL
the	NULL
panel	NULL
.	NULL

After	NULL
24	NULL
hours	NULL
of	NULL
growth	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
assayed	NULL
for	NULL
luciferase	NULL
activity	NULL
.	NULL

Increase	NULL
of	NULL
the	NULL
luciferase	NULL
activity	NULL
in	NULL
cell	NULL
extracts	NULL
is	NULL
shown	NULL
relative	NULL
to	NULL
that	NULL
after	NULL
parental	NULL
plasmid	NULL
transfection	NULL
.	NULL

The	NULL
mean	NULL
+	NULL
standard	NULL
error	NULL
of	NULL
mean	NULL
(	NULL
SEM	NULL
)	NULL
for	NULL
three	NULL
independent	NULL
assays	NULL
is	NULL
presented	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2366	NULL
already	NULL
undergone	NULL
proteolytic	NULL
degradation	NULL
.	NULL

IxBa	NULL
mRNA	NULL
was	NULL
upregulated	NULL
in	NULL
ATL	NULL
cells	NULL
of	NULL
patients	NULL
.	NULL

However	NULL
,	NULL
IxBa	NULL
protein	NULL
levels	NULL
did	NULL
not	NULL
increase	NULL
in	NULL
concert	NULL
with	NULL
the	NULL
highly	NULL
elevated	NULL
expression	NULL
of	NULL
the	NULL
mRNA	NULL
.	NULL

Furthermore	NULL
,	NULL
IxBa	NULL
protein	NULL
levels	NULL
were	NULL
significantly	NULL
lower	NULL
in	NULL
two	NULL
samples	NULL
.	NULL

Thus	NULL
,	NULL
increased	NULL
turnover	NULL
of	NULL
the	NULL
IxBa	NULL
protein	NULL
in	NULL
leukemic	NULL
cell	NULL
extracts	NULL
of	NULL
patients	NULL
with	NULL
ATL	NULL
was	NULL
associated	NULL
with	NULL
activation	NULL
of	NULL
NF-kB	NULL
.	NULL

These	NULL
results	NULL
were	NULL
similar	NULL
to	NULL
those	NULL
observed	NULL
in	NULL
HTLV-I-infected	NULL
and	NULL
Tax-expressing	NULL
T-cell	NULL
lines	NULL
.	NULL

Recently	NULL
,	NULL
like	NULL
IKBa	NULL
,	NULL
Tax-mediated	NULL
breakdown	NULL
of	NULL
IxBB	NULL
was	NULL
reported	NULL
.	NULL
``	NULL

In	NULL
preliminary	NULL
experiments	NULL
,	NULL
little	NULL
or	NULL
no	NULL
detectable	NULL
amount	NULL
of	NULL
IBB	NULL
was	NULL
found	NULL
in	NULL
primary	NULL
ATL	NULL
cells	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
degradation	NULL
of	NULL
IxBa	NULL
and	NULL
IKBB	NULL
may	NULL
play	NULL
a	NULL
role	NULL
in	NULL
the	NULL
constitutive	NULL
activation	NULL
of	NULL
NF-kB	NULL
in	NULL
ATL	NULL
.	NULL

Importantly	NULL
,	NULL
the	NULL
identity	NULL
of	NULL
the	NULL
shifted	NULL
bands	NULL
was	NULL
confirmed	NULL
by	NULL
supershifting	NULL
with	NULL
NF-	NULL
«	NULL
B-specific	NULL
antibodies	NULL
.	NULL

We	NULL
observed	NULL
that	NULL
the	NULL
dynamic	NULL
alterations	NULL
in	NULL
NF-KB	NULL
binding	NULL
activity	NULL
occurred	NULL
in	NULL
ATL	NULL
patients	NULL
.	NULL

In	NULL
all	NULL
patients	NULL
'	NULL
extracts	NULL
,	NULL
the	NULL
DNA	NULL
protein	NULL
complex	NULL
consists	NULL
of	NULL
p50/p65	NULL
heterodimers	NULL
and	NULL
p50	NULL
homodimers	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
NF-kB	NULL
binding	NULL
activity	NULL
in	NULL
healthy	NULL
subjects	NULL
was	NULL
composed	NULL
of	NULL
p50	NULL
homodimers	NULL
alone	NULL
.	NULL

Interestingly	NULL
,	NULL
cotransfection	NULL
with	NULL
various	NULL
NF-kB	NULL
subunits	NULL
indicated	NULL
that	NULL
p65	NULL
and	NULL
c-Rel	NULL
,	NULL
but	NULL
not	NULL
p50	NULL
,	NULL
was	NULL
able	NULL
to	NULL
activate	NULL
transcription	NULL
at	NULL
the	NULL
IL-2Ra	NULL
«	NULL
B	NULL
site	NULL
.	NULL

The	NULL
observation	NULL
that	NULL
constitutive	NULL
binding	NULL
of	NULL
heterodimeric	NULL
p50/p65	NULL
correlated	NULL
with	NULL
expression	NULL
of	NULL
IL-2Ra	NULL
in	NULL
ATL	NULL
patients	NULL
supports	NULL
the	NULL
notion	NULL
that	NULL
in	NULL
vivo	NULL
p50/p65	NULL
heterodimers	NULL
and	NULL
p50	NULL
homodimers	NULL
can	NULL
bind	NULL
to	NULL
the	NULL
kB	NULL
element	NULL
in	NULL
the	NULL
IL-2Ra	NULL
«	NULL
promoter	NULL
,	NULL
but	NULL
only	NULL
p50/p65	NULL
heterodimers	NULL
can	NULL
activate	NULL
transcription	NULL
.	NULL

HTLV-I	NULL
Tax	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
induce	NULL
a	NULL
degradation	NULL
of	NULL
IxBa	NULL
,	NULL
which	NULL
may	NULL
contribute	NULL
to	NULL
induce	NULL
the	NULL
nuclear	NULL
expression	NULL
of	NULL
a	NULL
number	NULL
of	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

l	NULL
species	NULL
.	NULL
``	NULL

''	NULL
NF-KB	NULL
is	NULL
known	NULL
to	NULL
mediate	NULL
the	NULL
Tax-dependent	NULL
transactivation	NULL
of	NULL
IL-2R	NULL
«	NULL
,	NULL
!	NULL

*	NULL
``	NULL
4	NULL
IL-1	NULL
,	NULL
``	NULL
TL-6	NULL
,	NULL
*	NULL
``	NULL
IL-8	NULL
,	NULL
``	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor	NULL
B	NULL
genes	NULL
.	NULL
``	NULL

''	NULL
Considering	NULL
the	NULL
previously	NULL
reported	NULL
enhanced	NULL
production	NULL
of	NULL
these	NULL
inflammatory	NULL
cytokines	NULL
``	NULL
>	NULL
426283	NULL
``	NULL
and	NULL
the	NULL
increased	NULL
expression	NULL
of	NULL
surface	NULL
molecules	NULL
such	NULL
as	NULL
IL-2R	NULL
«	NULL
&	NULL
``	NULL
in	NULL
leukemic	NULL
cells	NULL
of	NULL
ATL	NULL
patients	NULL
,	NULL
it	NULL
is	NULL
not	NULL
surprising	NULL
that	NULL
activated	NULL
NFP-	NULL
«	NULL
B/IxBa	NULL
pathway	NULL
was	NULL
seen	NULL
in	NULL
ATL	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
consistent	NULL
with	NULL
previous	NULL
studies	NULL
,	NULL
``	NULL
*	NULL
``	NULL
``	NULL
primary	NULL
leukemic	NULL
cells	NULL
isolated	NULL
from	NULL
ATL	NULL
patients	NULL
did	NULL
not	NULL
express	NULL
Tax	NULL
at	NULL
a	NULL
significant	NULL
level	NULL
.	NULL

Because	NULL
viral	NULL
expression	NULL
in	NULL
vivo	NULL
differs	NULL
significantly	NULL
from	NULL
that	NULL
observed	NULL
in	NULL
cell	NULL
lines	NULL
in	NULL
vitro	NULL
,	NULL
it	NULL
is	NULL
of	NULL
interest	NULL
to	NULL
understand	NULL
the	NULL
differences	NULL
of	NULL
NF-kB	NULL
activation	NULL
between	NULL
leukemic	NULL
cells	NULL
in	NULL
vivo	NULL
and	NULL
cell	NULL
lines	NULL
established	NULL
in	NULL
vitro	NULL
.	NULL

Tax	NULL
induces	NULL
predominantly	NULL
the	NULL
c-Rel-containing	NULL
complexes	NULL
``	NULL
and	NULL
transcriptionally	NULL
activates	NULL
the	NULL
c-Rel	NULL
gene	NULL
.	NULL
``	NULL

Consistent	NULL
with	NULL
these	NULL
studies	NULL
,	NULL
in	NULL
HTLV-L-infected	NULL
T	NULL
cells	NULL
that	NULL
constitutively	NULL
express	NULL
high	NULL
levels	NULL
of	NULL
Tax	NULL
,	NULL
p50	NULL
and	NULL
c-Rel	NULL
were	NULL
the	NULL
major	NULL
DNA	NULL
binding	NULL
components	NULL
;	NULL
similar	NULL
c-Rel	NULL
containing	NULL
complexes	NULL
were	NULL
also	NULL
observed	NULL
previously	NULL
,	NULL
'	NULL
``	NULL
``	NULL
>	NULL
``	NULL
suggesting	NULL
Tax-independent	NULL
mechanisms	NULL
by	NULL
which	NULL
primary	NULL
ATL	NULL
cells	NULL
exhibit	NULL
persistent	NULL
nuclear	NULL
expression	NULL
of	NULL
p50/p65	NULL
heterodimers	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
ATL-derived	NULL
TL-Om1	NULL
cell	NULL
line	NULL
fails	NULL
to	NULL
express	NULL
detectable	NULL
levels	NULL
of	NULL
Tax	NULL
.	NULL

However	NULL
,	NULL
TL-Om1	NULL
was	NULL
shown	NULL
to	NULL
carry	NULL
full-length	NULL
proviral	NULL
genome	NULL
of	NULL
HTLV-I	NULL
by	NULL
Southern	NULL
blot	NULL
analysis	NULL
.	NULL
``	NULL

''	NULL
It	NULL
was	NULL
also	NULL
found	NULL
that	NULL
the	NULL
HTLV-I	NULL
LTR	NULL
function	NULL
was	NULL
not	NULL
enhanced	NULL
in	NULL
TL-Om1	NULL
,	NULL
as	NULL
the	NULL
LTR	NULL
luciferase	NULL
activity	NULL
in	NULL
TL-Om|1	NULL
was	NULL
one	NULL
fourteenth	NULL
of	NULL
that	NULL
in	NULL
MORI	NULL
ET	NULL
AL	NULL
MT-2	NULL
.	NULL

Furthermore	NULL
,	NULL
Tax	NULL
induced	NULL
transcription	NULL
from	NULL
the	NULL
LTR	NULL
in	NULL
TL-Om1	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
have	NULL
also	NULL
shown	NULL
the	NULL
rapid	NULL
degradation	NULL
of	NULL
IxBa	NULL
in	NULL
TL-Om1	NULL
cells	NULL
,	NULL
which	NULL
may	NULL
be	NULL
directly	NULL
involved	NULL
in	NULL
constitutive	NULL
NF-kB	NULL
activation	NULL
.	NULL

This	NULL
line	NULL
still	NULL
expresses	NULL
IL-2Ra	NULL
mRNA	NULL
and	NULL
protein	NULL
at	NULL
high	NULL
levels	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
TL-Om	NULL
!	NULL

1	NULL
cells	NULL
express	NULL
chemokine	NULL
genes	NULL
such	NULL
as	NULL
IP-10	NULL
and	NULL
1309	NULL
,	NULL
and	NULL
intercellular	NULL
adhesion	NULL
molecule	NULL
1	NULL
at	NULL
the	NULL
same	NULL
levels	NULL
as	NULL
those	NULL
in	NULL
Tax-expressing	NULL
T-cell	NULL
lines	NULL
infected	NULL
with	NULL
HTLV-L.45°	NULL
These	NULL
results	NULL
suggest	NULL
that	NULL
Tax	NULL
is	NULL
not	NULL
the	NULL
only	NULL
mechanism	NULL
for	NULL
constitutive	NULL
expression	NULL
of	NULL
certain	NULL
cellular	NULL
genes	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

We	NULL
believe	NULL
in	NULL
the	NULL
possibility	NULL
of	NULL
Tax-independent	NULL
mechanisms	NULL
operating	NULL
for	NULL
constitutive	NULL
activation	NULL
in	NULL
leukemic	NULL
cells	NULL
of	NULL
ATL	NULL
patients	NULL
.	NULL

TL-Om1	NULL
should	NULL
help	NULL
to	NULL
identify	NULL
new	NULL
targets	NULL
of	NULL
NF-kB	NULL
by	NULL
comparing	NULL
gene	NULL
expression	NULL
between	NULL
this	NULL
cell	NULL
line	NULL
and	NULL
other	NULL
Tax-expressing	NULL
cell	NULL
lines	NULL
.	NULL

ACKNOWLEDGMENT	NULL
We	NULL
thank	NULL
Drs	NULL
T.	NULL
Taniguchi	NULL
,	NULL
J.	NULL
Fujisawa	NULL
,	NULL
and	NULL
K.	NULL
Yamamoto	NULL
for	NULL
providing	NULL
plasmids	NULL
,	NULL
Dr	NULL
M.	NULL
Nakamura	NULL
for	NULL
providing	NULL
JPX-9	NULL
,	NULL
and	NULL
Fujisaki	NULL
Cell	NULL
Center	NULL
,	NULL
Hayashibara	NULL
Biochemical	NULL
Laboratories	NULL
Inc	NULL
(	NULL
Okayama	NULL
,	NULL
Japan	NULL
)	NULL
for	NULL
providing	NULL
Jurkat	NULL
,	NULL
HUT-102	NULL
,	NULL
and	NULL
C5/MJ	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
Dr	NULL
Y.	NULL
Yamasaki	NULL
for	NULL
providing	NULL
blood	NULL
of	NULL
ATL	NULL
patients	NULL
and	NULL
M.	NULL
Yamamoto	NULL
and	NULL
M.	NULL
Sasaki	NULL
for	NULL
excellent	NULL
technical	NULL
assistance	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Poiesz	NULL
BJ	NULL
,	NULL
Ruscetti	NULL
FW	NULL
,	NULL
Gazdar	NULL
AF	NULL
,	NULL
Bunn	NULL
PA	NULL
,	NULL
Minna	NULL
JD	NULL
,	NULL
Gallo	NULL
RC	NULL
:	NULL
Detection	NULL
and	NULL
isolation	NULL
of	NULL
type	NULL
C	NULL
retrovirus	NULL
particles	NULL
from	NULL
fresh	NULL
and	NULL
cultured	NULL
lymphocytes	NULL
of	NULL
a	NULL
patient	NULL
with	NULL
cutaneous	NULL
T-cell	NULL
lymphoma	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
77:7415	NULL
,	NULL
1980	NULL
2	NULL
.	NULL

Yoshida	NULL
M	NULL
,	NULL
Miyoshi	NULL
I	NULL
,	NULL
Hinuma	NULL
Y	NULL
:	NULL
Isolation	NULL
and	NULL
characterization	NULL
of	NULL
retrovirus	NULL
from	NULL
cell	NULL
lines	NULL
of	NULL
human	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
and	NULL
its	NULL
implication	NULL
in	NULL
the	NULL
disease	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
79:2031	NULL
,	NULL
1982	NULL
3	NULL
.	NULL

Wong-Staal	NULL
F	NULL
,	NULL
Gallo	NULL
RC	NULL
:	NULL
Human	NULL
T-lymphotropic	NULL
retroviruses	NULL
.	NULL

Nature	NULL
317:395	NULL
,	NULL
1985	NULL
4	NULL
.	NULL

Seiki	NULL
M	NULL
,	NULL
Eddy	NULL
R	NULL
,	NULL
Shows	NULL
TB	NULL
,	NULL
Yoshida	NULL
M	NULL
:	NULL
Nonspecific	NULL
integration	NULL
of	NULL
the	NULL
HTLV	NULL
provirus	NULL
genome	NULL
into	NULL
adult	NULL
T-cell	NULL
leukaemia	NULL
cells	NULL
.	NULL

Nature	NULL
309:640	NULL
,	NULL
1984	NULL
5	NULL
.	NULL

Felber	NULL
BK	NULL
,	NULL
Paskalis	NULL
H	NULL
,	NULL
Kleinman-Ewing	NULL
C	NULL
,	NULL
Wong-Staal	NULL
F	NULL
,	NULL
Pavlakis	NULL
GN	NULL
:	NULL
The	NULL
pX	NULL
protein	NULL
of	NULL
HTLV-I	NULL
is	NULL
a	NULL
transcriptional	NULL
activator	NULL
of	NULL
its	NULL
long	NULL
terminal	NULL
repeats	NULL
.	NULL

Science	NULL
229:675	NULL
,	NULL
1985	NULL
6	NULL
.	NULL

Sodroski	NULL
JG	NULL
,	NULL
Rosen	NULL
CA	NULL
,	NULL
Haseltine	NULL
WA	NULL
:	NULL
Trans-acting	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
of	NULL
human	NULL
T	NULL
lymphotropic	NULL
viruses	NULL
in	NULL
infected	NULL
cells	NULL
.	NULL

Science	NULL
225:381	NULL
,	NULL
1984	NULL
7	NULL
.	NULL

Maruyama	NULL
M	NULL
,	NULL
Shibuya	NULL
H	NULL
,	NULL
Harada	NULL
H	NULL
,	NULL
Hatakeyama	NULL
M	NULL
,	NULL
Seiki	NULL
M	NULL
,	NULL
Fujita	NULL
T	NULL
,	NULL
Inoue	NULL
J	NULL
,	NULL
Yoshida	NULL
M	NULL
,	NULL
Taniguchi	NULL
T	NULL
:	NULL
Evidence	NULL
for	NULL
aberrant	NULL
activation	NULL
of	NULL
the	NULL
interleukin-2	NULL
autocrine	NULL
loop	NULL
by	NULL
HTLV-1-encoded	NULL
p40*®	NULL
and	NULL
T3/Ti	NULL
complex	NULL
triggering	NULL
.	NULL

Cell	NULL
48:343	NULL
,	NULL
1987	NULL
8	NULL
.	NULL

Sickevitz	NULL
M	NULL
,	NULL
Feinberg	NULL
MB	NULL
,	NULL
Holbrook	NULL
N	NULL
,	NULL
Wong-Staal	NULL
F	NULL
,	NULL
Greene	NULL
WC	NULL
:	NULL
Activation	NULL
of	NULL
interleukin	NULL
2	NULL
and	NULL
interleukin	NULL
2	NULL
receptor	NULL
(	NULL
Tac	NULL
)	NULL
promoter	NULL
expression	NULL
by	NULL
the	NULL
trans-activator	NULL
(	NULL
at	NULL
)	NULL
gene	NULL
product	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I.	NULL
Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
84:5389	NULL
,	NULL
1987	NULL
9	NULL
.	NULL

Cross	NULL
SL	NULL
,	NULL
Feinberg	NULL
MB	NULL
,	NULL
Wolf	NULL
JB	NULL
,	NULL
Holbrook	NULL
NJ	NULL
,	NULL
Wong-Staal	NULL
F	NULL
,	NULL
Leonard	NULL
WJ	NULL
:	NULL
Regulation	NULL
of	NULL
the	NULL
human	NULL
interleukin-2	NULL
receptor	NULL
&	NULL
chain	NULL
promoter	NULL
:	NULL
Activation	NULL
of	NULL
a	NULL
nonfunctional	NULL
promoter	NULL
by	NULL
the	NULL
transactivator	NULL
gene	NULL
of	NULL
HTLV-I	NULL
Cell	NULL
49:47	NULL
,	NULL
1987	NULL
10	NULL
.	NULL

Inoue	NULL
J	NULL
,	NULL
Seiki	NULL
M	NULL
,	NULL
Taniguchi	NULL
T	NULL
,	NULL
Tsuru	NULL
S	NULL
,	NULL
Yoshida	NULL
M	NULL
:	NULL
Induction	NULL
of	NULL
interleukin	NULL
2	NULL
receptor	NULL
gene	NULL
expression	NULL
by	NULL
p40*	NULL
encoded	NULL
by	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
.	NULL

EMBO	NULL
J	NULL
5:2883	NULL
,	NULL
1986	NULL
11	NULL
.	NULL

Smith	NULL
MR	NULL
,	NULL
Greene	NULL
WC	NULL
:	NULL
Molecular	NULL
biology	NULL
of	NULL
type	NULL
I	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
(	NULL
HTLV-I	NULL
)	NULL
and	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
87:761	NULL
,	NULL
1991	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

NF-kB	NULL
ACTIVATION	NULL
IN	NULL
ATL	NULL
12	NULL
.	NULL

Ballard	NULL
DW	NULL
,	NULL
Bohnlein	NULL
E	NULL
,	NULL
Lowenthal	NULL
JW	NULL
,	NULL
Wano	NULL
Y	NULL
,	NULL
Franza	NULL
BR	NULL
,	NULL
Greene	NULL
WC	NULL
:	NULL
HTLV-I	NULL
tax	NULL
induces	NULL
cellular	NULL
proteins	NULL
that	NULL
activate	NULL
the	NULL
«	NULL
B	NULL
element	NULL
in	NULL
the	NULL
IL-2	NULL
receptor	NULL
«	NULL
gene	NULL
.	NULL

Science	NULL
241:1652	NULL
,	NULL
1988	NULL
13	NULL
.	NULL

Crenon	NULL
I	NULL
,	NULL
Beraud	NULL
C	NULL
,	NULL
Simard	NULL
P	NULL
,	NULL
Montagne	NULL
J	NULL
,	NULL
Veschambre	NULL
P	NULL
,	NULL
Jalinot	NULL
P	NULL
:	NULL
The	NULL
transcriptionally	NULL
active	NULL
factors	NULL
mediating	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
HTLV-I	NULL
Tax	NULL
transactivator	NULL
on	NULL
the	NULL
IL-2R	NULL
«	NULL
B	NULL
enhancer	NULL
include	NULL
the	NULL
product	NULL
of	NULL
the	NULL
c-rel	NULL
proto-oncogene	NULL
.	NULL

Oncogene	NULL
8:867	NULL
,	NULL
1993	NULL
14	NULL
.	NULL

Ruben	NULL
S	NULL
,	NULL
Poteat	NULL
H	NULL
,	NULL
Tan	NULL
T-H	NULL
,	NULL
Kawakami	NULL
K	NULL
,	NULL
Roeder	NULL
R	NULL
,	NULL
Haseltine	NULL
W	NULL
,	NULL
Rosen	NULL
CA	NULL
:	NULL
Cellular	NULL
transcription	NULL
factors	NULL
and	NULL
regulation	NULL
of	NULL
the	NULL
IL-2	NULL
receptor	NULL
gene	NULL
expression	NULL
by	NULL
HTLV-I	NULL
tax	NULL
gene	NULL
product	NULL
.	NULL

Science	NULL
241:89	NULL
,	NULL
1988	NULL
15	NULL
.	NULL

Bacuerle	NULL
PA	NULL
,	NULL
Baltimore	NULL
D	NULL
:	NULL
IB	NULL
:	NULL
A	NULL
specific	NULL
inhibitor	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
.	NULL

Science	NULL
242:540	NULL
,	NULL
1988	NULL
16	NULL
.	NULL

Brown	NULL
K	NULL
,	NULL
Park	NULL
S	NULL
,	NULL
Kanno	NULL
T	NULL
,	NULL
Franzoso	NULL
G	NULL
,	NULL
Siebenlist	NULL
U	NULL
:	NULL
Mutual	NULL
regulation	NULL
of	NULL
the	NULL
transcriptional	NULL
activator	NULL
NF-xB	NULL
and	NULL
its	NULL
inhibitor	NULL
,	NULL
IxBe..	NULL
Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
90:2532	NULL
,	NULL
1993	NULL
17	NULL
.	NULL

Kanno	NULL
T	NULL
,	NULL
Brown	NULL
K	NULL
,	NULL
Franzoso	NULL
G	NULL
,	NULL
Siecbenlist	NULL
U	NULL
:	NULL
Kinetic	NULL
analysis	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
Tax-mediated	NULL
activation	NULL
of	NULL
NF-kB	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
14:6443	NULL
,	NULL
1994	NULL
18	NULL
.	NULL

Sun	NULL
S-C	NULL
,	NULL
Elwood	NULL
J	NULL
,	NULL
Beraud	NULL
C	NULL
,	NULL
Greene	NULL
WC	NULL
:	NULL
Human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
Tax	NULL
activation	NULL
of	NULL
NF-xB/Re	NULL
!	NULL

l	NULL
involves	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
of	NULL
IxBa	NULL
and	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
-mediated	NULL
induction	NULL
of	NULL
the	NULL
c-rel	NULL
gene	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
14:7377	NULL
,	NULL
1994	NULL
19	NULL
.	NULL

Lacoste	NULL
J	NULL
,	NULL
Petropoulos	NULL
L	NULL
,	NULL
Pepin	NULL
N	NULL
,	NULL
Hiscott	NULL
J	NULL
:	NULL
Constitutive	NULL
phosphorylation	NULL
and	NULL
turnover	NULL
of	NULL
in	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
-infected	NULL
and	NULL
Tax-expressing	NULL
T	NULL
cells	NULL
.	NULL

J	NULL
Virol	NULL
69:564	NULL
,	NULL
1995	NULL
20	NULL
.	NULL

Brockman	NULL
JA	NULL
,	NULL
Scherer	NULL
DC	NULL
,	NULL
McKinsey	NULL
TA	NULL
,	NULL
Hall	NULL
SM	NULL
,	NULL
Qi	NULL
X	NULL
,	NULL
Lee	NULL
WY	NULL
,	NULL
Ballard	NULL
DW	NULL
:	NULL
Coupling	NULL
of	NULL
a	NULL
signal	NULL
response	NULL
domain	NULL
in	NULL
IxBa	NULL
to	NULL
multiple	NULL
pathways	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
15:2809	NULL
,	NULL
1995	NULL
21	NULL
.	NULL

Suzuki	NULL
T	NULL
,	NULL
Hirai	NULL
H	NULL
,	NULL
Murakami	NULL
T	NULL
,	NULL
Yoshida	NULL
M	NULL
:	NULL
Tax	NULL
protein	NULL
of	NULL
HTLV-1	NULL
destabilizes	NULL
the	NULL
complexes	NULL
of	NULL
NF-kB	NULL
and	NULL
IxB-	NULL
«	NULL
and	NULL
induces	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
for	NULL
transcriptional	NULL
activation	NULL
.	NULL

Oncogene	NULL
10:1199	NULL
,	NULL
1995	NULL
22	NULL
.	NULL

Uchiyama	NULL
T	NULL
,	NULL
Hori	NULL
T	NULL
,	NULL
Tsudo	NULL
M	NULL
,	NULL
Wano	NULL
Y	NULL
,	NULL
Umadome	NULL
H	NULL
,	NULL
Tamori	NULL
S	NULL
,	NULL
Yodoi	NULL
J	NULL
,	NULL
Maeda	NULL
M	NULL
,	NULL
Sawami	NULL
H	NULL
,	NULL
Uchino	NULL
H	NULL
:	NULL
Interleukin-2	NULL
receptor	NULL
(	NULL
Tac	NULL
antigen	NULL
)	NULL
expressed	NULL
on	NULL
adult	NULL
T	NULL
cell	NULL
leukemia	NULL
cells	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
76:446	NULL
,	NULL
1985	NULL
23	NULL
.	NULL

Kodaka	NULL
T	NULL
,	NULL
Uchiyama	NULL
T	NULL
,	NULL
Umadome	NULL
H	NULL
,	NULL
Uchino	NULL
H	NULL
;	NULL
:	NULL
Expression	NULL
of	NULL
cytokine	NULL
mRNA	NULL
in	NULL
leukemic	NULL
cells	NULL
from	NULL
adult	NULL
T	NULL
cell	NULL
leukemia	NULL
patients	NULL
.	NULL

Jpn	NULL
J	NULL
Cancer	NULL
Res	NULL
80:531	NULL
,	NULL
1989	NULL
24	NULL
.	NULL

Mori	NULL
N	NULL
,	NULL
Shirakawa	NULL
F	NULL
,	NULL
Murakami	NULL
S	NULL
,	NULL
Oda	NULL
S	NULL
,	NULL
Eto	NULL
S	NULL
:	NULL
Interleukin-4	NULL
inhibits	NULL
the	NULL
production	NULL
of	NULL
interleukin-1	NULL
by	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
cells	NULL
.	NULL

Eur	NULL
J	NULL
Haematol	NULL
55:121	NULL
,	NULL
1995	NULL
25	NULL
.	NULL

Wano	NULL
Y	NULL
,	NULL
Hattori	NULL
T	NULL
,	NULL
Matsuoka	NULL
M	NULL
,	NULL
Takatsuki	NULL
K	NULL
,	NULL
Chua	NULL
AO	NULL
,	NULL
Gubler	NULL
U	NULL
,	NULL
Greene	NULL
WC	NULL
:	NULL
Interleukin	NULL
1	NULL
gene	NULL
expression	NULL
in	NULL
adult	NULL
T	NULL
cell	NULL
leukemia	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
80:911	NULL
,	NULL
1987	NULL
26	NULL
.	NULL

Mori	NULL
N	NULL
,	NULL
Shirakawa	NULL
F	NULL
,	NULL
Murakami	NULL
S	NULL
,	NULL
Oda	NULL
S	NULL
,	NULL
Eto	NULL
S	NULL
:	NULL
Inhibitory	NULL
effect	NULL
of	NULL
interleukin	NULL
4	NULL
on	NULL
production	NULL
of	NULL
interleukin	NULL
6	NULL
by	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
cells	NULL
.	NULL

Cancer	NULL
Res	NULL
53:4643	NULL
,	NULL
1993	NULL
27	NULL
.	NULL

Mori	NULL
N	NULL
,	NULL
Shirakawa	NULL
F	NULL
,	NULL
Shimizu	NULL
H	NULL
,	NULL
Murakami	NULL
S	NULL
,	NULL
Oda	NULL
S	NULL
,	NULL
Yamamoto	NULL
K	NULL
,	NULL
Eto	NULL
S	NULL
:	NULL
Transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
human	NULL
interleukin-6	NULL
gene	NULL
promoter	NULL
in	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
T	NULL
cell	NULL
lines	NULL
:	NULL
Evidence	NULL
for	NULL
the	NULL
involvement	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Blood	NULL
84:2904	NULL
,	NULL
1994	NULL
28	NULL
.	NULL

Mori	NULL
N	NULL
,	NULL
Murakami	NULL
S	NULL
,	NULL
Oda	NULL
S	NULL
,	NULL
Prager	NULL
D	NULL
,	NULL
Eto	NULL
S	NULL
:	NULL
Production	NULL
of	NULL
interleukin	NULL
8	NULL
in	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
cells	NULL
:	NULL
Possible	NULL
transactivation	NULL
of	NULL
the	NULL
interleukin	NULL
8	NULL
gene	NULL
by	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
tax	NULL
.	NULL

Cancer	NULL
Res	NULL
55:3592	NULL
,	NULL
1995	NULL
29	NULL
.	NULL

Matsushita	NULL
K	NULL
,	NULL
Arima	NULL
N	NULL
,	NULL
Ohtsubo	NULL
H	NULL
,	NULL
Fujiwara	NULL
H	NULL
,	NULL
Hidaka	NULL
S	NULL
,	NULL
Fukumori	NULL
J	NULL
,	NULL
Tanaka	NULL
H	NULL
;	NULL
Frequent	NULL
expression	NULL
of	NULL
interleukin-9	NULL
mRNA	NULL
and	NULL
infrequent	NULL
involvement	NULL
of	NULL
interleukin-9	NULL
in	NULL
proliferation	NULL
of	NULL
primary	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
cells	NULL
and	NULL
HTLV-I	NULL
infected	NULL
T-cell	NULL
lines	NULL
.	NULL

Leuk	NULL
Res	NULL
21:211	NULL
,	NULL
1997	NULL
30	NULL
.	NULL

Mori	NULL
N	NULL
,	NULL
Gill	NULL
PS	NULL
,	NULL
Mougdil	NULL
T	NULL
,	NULL
Murakami	NULL
S	NULL
,	NULL
Eto	NULL
S	NULL
,	NULL
Prager	NULL
D	NULL
:	NULL
Interleukin-10	NULL
gene	NULL
expression	NULL
in	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
.	NULL

Blood	NULL
88:1035	NULL
,	NULL
1996	NULL
2367	NULL
31	NULL
.	NULL

Ishibashi	NULL
K	NULL
,	NULL
Ishitsuka	NULL
K	NULL
,	NULL
Chuman	NULL
Y	NULL
,	NULL
Otsuka	NULL
M	NULL
,	NULL
Kuwazuru	NULL
Y	NULL
,	NULL
Iwahashi	NULL
M	NULL
,	NULL
Utsunomiya	NULL
A	NULL
,	NULL
Hanada	NULL
S	NULL
,	NULL
Sakurami	NULL
T	NULL
,	NULL
Arima	NULL
T	NULL
:	NULL
Tumor	NULL
necrosis	NULL
factor-B	NULL
in	NULL
the	NULL
serum	NULL
of	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
with	NULL
hypercalce-mia	NULL
.	NULL

Blood	NULL
77:2451	NULL
,	NULL
1991	NULL
32	NULL
.	NULL

Niitsu	NULL
Y	NULL
,	NULL
Urushizaki	NULL
Y	NULL
,	NULL
Koshida	NULL
Y	NULL
,	NULL
Terui	NULL
K	NULL
,	NULL
Mahara	NULL
K	NULL
,	NULL
Kohgo	NULL
Y	NULL
,	NULL
Urushizaki	NULL
I	NULL
:	NULL
Expression	NULL
of	NULL
TGF-beta	NULL
in	NULL
adult	NULL
T	NULL
cell	NULL
leukemia	NULL
.	NULL

Blood	NULL
71:263	NULL
,	NULL
1988	NULL
33	NULL
.	NULL

Kim	NULL
S-J	NULL
,	NULL
Kebrl	NULL
JH	NULL
,	NULL
Burton	NULL
J	NULL
,	NULL
Tendler	NULL
CL	NULL
,	NULL
Jeang	NULL
K-T	NULL
,	NULL
Danielpour	NULL
D	NULL
,	NULL
Thevenin	NULL
C	NULL
,	NULL
Kim	NULL
KY	NULL
,	NULL
Sporn	NULL
MB	NULL
,	NULL
Roberts	NULL
AB	NULL
:	NULL
Transactivation	NULL
of	NULL
the	NULL
transforming	NULL
growth	NULL
factor	NULL
B1	NULL
(	NULL
TGF-B1	NULL
)	NULL
gene	NULL
by	NULL
human	NULL
T	NULL
lymphotropic	NULL
virus	NULL
type	NULL
1	NULL
Tax	NULL
:	NULL
A	NULL
potential	NULL
mechanism	NULL
for	NULL
the	NULL
increased	NULL
production	NULL
of	NULL
TGF-B1	NULL
in	NULL
adult	NULL
T	NULL
cell	NULL
leukemia	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
172:121	NULL
,	NULL
1990	NULL
34	NULL
.	NULL

Honda	NULL
S	NULL
,	NULL
Yamaguchi	NULL
K	NULL
,	NULL
Miyake	NULL
Y	NULL
,	NULL
Hayashi	NULL
N	NULL
,	NULL
Adachi	NULL
N	NULL
,	NULL
Kinoshita	NULL
K	NULL
,	NULL
Ikehara	NULL
O	NULL
,	NULL
Kimura	NULL
S	NULL
,	NULL
Kinoshita	NULL
T	NULL
,	NULL
Shimotohno	NULL
K	NULL
,	NULL
Shimoyama	NULL
M	NULL
,	NULL
Abe	NULL
K	NULL
:	NULL
Production	NULL
of	NULL
parathyroid	NULL
hormone-related	NULL
protein	NULL
in	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
cells	NULL
.	NULL

Jpn	NULL
J	NULL
Cancer	NULL
Res	NULL
79:1264	NULL
,	NULL
1988	NULL
35	NULL
.	NULL

Watanabe	NULL
T	NULL
,	NULL
Yamaguchi	NULL
K	NULL
,	NULL
Takatsuki	NULL
K	NULL
,	NULL
Osame	NULL
M	NULL
,	NULL
Yoshida	NULL
M	NULL
:	NULL
Constitutive	NULL
expression	NULL
of	NULL
parathyroid	NULL
hormone-related	NULL
protein	NULL
gene	NULL
in	NULL
human	NULL
T	NULL
cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HTLV-1	NULL
)	NULL
carriers	NULL
and	NULL
adult	NULL
T	NULL
cell	NULL
leukemia	NULL
patients	NULL
that	NULL
can	NULL
be	NULL
frans-activated	NULL
by	NULL
HTLV-1	NULL
fax	NULL
gene	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
172:759	NULL
,	NULL
1990	NULL
36	NULL
.	NULL

Mori	NULL
N	NULL
,	NULL
Prager	NULL
D	NULL
:	NULL
Transactivation	NULL
of	NULL
the	NULL
interleukin-la	NULL
promoter	NULL
by	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
and	NULL
type	NULL
II	NULL
Tax	NULL
proteins	NULL
.	NULL

Blood	NULL
87:3410	NULL
,	NULL
1996	NULL
37	NULL
.	NULL

Tschachler	NULL
E	NULL
,	NULL
Bohnlein	NULL
E	NULL
,	NULL
Felzman	NULL
S	NULL
,	NULL
Reitz	NULL
MJ	NULL
:	NULL
Human	NULL
T	NULL
lymphotropic	NULL
virus	NULL
type	NULL
I	NULL
tax	NULL
regulates	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
human	NULL
lymphotoxin	NULL
gene	NULL
.	NULL

Blood	NULL
81:95	NULL
,	NULL
1993	NULL
38	NULL
.	NULL

Kinoshita	NULL
T	NULL
,	NULL
Shimoyama	NULL
M	NULL
,	NULL
Tobinai	NULL
K	NULL
,	NULL
Ito	NULL
M	NULL
,	NULL
Ito	NULL
S	NULL
,	NULL
Ikeda	NULL
S	NULL
,	NULL
Tajima	NULL
K	NULL
,	NULL
Shimotohno	NULL
K	NULL
,	NULL
Sugimura	NULL
T	NULL
:	NULL
Detection	NULL
of	NULL
mRNA	NULL
for	NULL
the	NULL
tax	NULL
;	NULL
/rex	NULL
,	NULL
gene	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
in	NULL
fresh	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
of	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
patients	NULL
and	NULL
viral	NULL
carriers	NULL
by	NULL
using	NULL
the	NULL
polymerase	NULL
chain	NULL
reaction	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
86:5620	NULL
,	NULL
1989	NULL
39	NULL
.	NULL

Furukawa	NULL
Y	NULL
,	NULL
Osame	NULL
M	NULL
,	NULL
Kubota	NULL
R	NULL
,	NULL
Tara	NULL
M	NULL
,	NULL
Yoshida	NULL
M	NULL
:	NULL
Human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type-1	NULL
(	NULL
HTLV-1	NULL
)	NULL
Tax	NULL
is	NULL
expressed	NULL
at	NULL
the	NULL
same	NULL
level	NULL
in	NULL
infected	NULL
cells	NULL
of	NULL
HTLV-l-associated	NULL
myelopathy	NULL
or	NULL
tropical	NULL
spastic	NULL
paraparesis	NULL
patients	NULL
as	NULL
in	NULL
asymptomatic	NULL
carriers	NULL
but	NULL
at	NULL
a	NULL
lower	NULL
level	NULL
in	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
cells	NULL
.	NULL

Blood	NULL
85:1865	NULL
,	NULL
1995	NULL
40	NULL
.	NULL

Ohtani	NULL
K	NULL
,	NULL
Nakamura	NULL
M	NULL
,	NULL
Saito	NULL
S	NULL
,	NULL
Nagata	NULL
K	NULL
,	NULL
Sugamura	NULL
K	NULL
,	NULL
Hinuma	NULL
Y	NULL
:	NULL
Electroporation	NULL
:	NULL
Application	NULL
to	NULL
human	NULL
lymphoid	NULL
cell	NULL
lines	NULL
for	NULL
stable	NULL
introduction	NULL
of	NULL
a	NULL
transactivator	NULL
gene	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I.	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
17:1589	NULL
,	NULL
1989	NULL
41	NULL
.	NULL

Shimoyama	NULL
M	NULL
:	NULL
Diagnostic	NULL
criteria	NULL
and	NULL
classification	NULL
of	NULL
clinical	NULL
subtypes	NULL
of	NULL
adult	NULL
T-cell	NULL
leukaemia-lymphoma	NULL
.	NULL

A	NULL
report	NULL
from	NULL
the	NULL
Lymphoma	NULL
Study	NULL
Group	NULL
(	NULL
1984-1987	NULL
)	NULL
.	NULL

Br	NULL
J	NULL
Haematol	NULL
79:428	NULL
,	NULL
1991	NULL
42	NULL
.	NULL

Haskill	NULL
S	NULL
,	NULL
Beg	NULL
AA	NULL
,	NULL
Tompkins	NULL
SM	NULL
,	NULL
Morris	NULL
JS	NULL
,	NULL
Yurochko	NULL
AD	NULL
,	NULL
Sampson-Johannes	NULL
A	NULL
,	NULL
Mondal	NULL
K	NULL
,	NULL
Ralph	NULL
P	NULL
,	NULL
Baldwin	NULL
AS	NULL
Jr	NULL
:	NULL
Characterization	NULL
of	NULL
an	NULL
immediate-early	NULL
gene	NULL
induced	NULL
in	NULL
adherent	NULL
monocytes	NULL
that	NULL
encodes	NULL
IxB-like	NULL
activity	NULL
.	NULL

Cell	NULL
65:1281	NULL
,	NULL
1991	NULL
43	NULL
.	NULL

Hatakeyama	NULL
M	NULL
,	NULL
Minamoto	NULL
S	NULL
,	NULL
Uchiyama	NULL
T	NULL
,	NULL
Hardy	NULL
RR	NULL
,	NULL
Yamada	NULL
G	NULL
,	NULL
Taniguchi	NULL
T	NULL
:	NULL
Reconstitution	NULL
of	NULL
functional	NULL
receptor	NULL
for	NULL
human	NULL
interleukin-2	NULL
in	NULL
mouse	NULL
cells	NULL
.	NULL

Nature	NULL
318:467	NULL
,	NULL
1985	NULL
44	NULL
.	NULL

Benham	NULL
FJ	NULL
,	NULL
Hodgkinson	NULL
S	NULL
,	NULL
Davies	NULL
KE	NULL
:	NULL
A	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
pseudogene	NULL
on	NULL
the	NULL
short	NULL
arm	NULL
of	NULL
the	NULL
human	NULL
X	NULL
chromosomes	NULL
defines	NULL
a	NULL
multigene	NULL
family	NULL
.	NULL

EMBO	NULL
J	NULL
3:2635	NULL
,	NULL
1984	NULL
45	NULL
.	NULL

Seiki	NULL
M	NULL
,	NULL
Hikikoshi	NULL
A	NULL
,	NULL
Taniguchi	NULL
T	NULL
,	NULL
Yoshida	NULL
M	NULL
:	NULL
Expression	NULL
of	NULL
the	NULL
pX	NULL
gene	NULL
of	NULL
HTLV-I	NULL
:	NULL
General	NULL
splicing	NULL
mechanism	NULL
in	NULL
the	NULL
HTLV	NULL
family	NULL
.	NULL

Science	NULL
228:1532	NULL
,	NULL
1985	NULL
46	NULL
.	NULL

Molitor	NULL
JA	NULL
,	NULL
Walker	NULL
WH	NULL
,	NULL
Doetre	NULL
S	NULL
,	NULL
Ballard	NULL
DW	NULL
,	NULL
Greene	NULL
WC	NULL
:	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
A	NULL
family	NULL
of	NULL
inducible	NULL
and	NULL
differentially	NULL
expressed	NULL
enhancer-binding	NULL
proteins	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
87:10028	NULL
,	NULL
1990	NULL
47	NULL
.	NULL

Antalis	NULL
TM	NULL
,	NULL
Godbolt	NULL
D	NULL
:	NULL
Isolation	NULL
nuclei	NULL
from	NULL
hematopoietic	NULL
cell	NULL
types	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
19:4301	NULL
,	NULL
1991	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2368	NULL
48	NULL
.	NULL

Sugamura	NULL
K	NULL
,	NULL
Fujii	NULL
M	NULL
,	NULL
Kannagi	NULL
M	NULL
,	NULL
Sakitani	NULL
M	NULL
,	NULL
Takeuchi	NULL
M	NULL
,	NULL
Hinuma	NULL
Y	NULL
:	NULL
Cell	NULL
surface	NULL
phenotypes	NULL
and	NULL
expression	NULL
of	NULL
viral	NULL
antigens	NULL
of	NULL
various	NULL
human	NULL
cell	NULL
lines	NULL
carrying	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
.	NULL

Int	NULL
J	NULL
Cancer	NULL
34:221	NULL
,	NULL
1984	NULL
49	NULL
.	NULL

Fukudome	NULL
K	NULL
,	NULL
Furuse	NULL
M	NULL
,	NULL
Fukuhara	NULL
N	NULL
,	NULL
Orita	NULL
S	NULL
,	NULL
Imai	NULL
T	NULL
,	NULL
Takagi	NULL
S	NULL
,	NULL
Nagira	NULL
M	NULL
,	NULL
Hinuma	NULL
Y	NULL
,	NULL
Yoshie	NULL
O	NULL
:	NULL
Strong	NULL
induction	NULL
of	NULL
ICAM-1	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
transformed	NULL
by	NULL
human	NULL
T-cell-leukemia	NULL
virus	NULL
type	NULL
1	NULL
and	NULL
depression	NULL
of	NULL
ICAM-1	NULL
or	NULL
LFA-1	NULL
in	NULL
adult	NULL
T-cell-leukemia-derived	NULL
cell	NULL
lines	NULL
.	NULL

Int	NULL
J	NULL
Cancer	NULL
52:418	NULL
,	NULL
1992	NULL
50	NULL
.	NULL

Sodroski	NULL
J	NULL
,	NULL
Rosen	NULL
C	NULL
,	NULL
Goh	NULL
WC	NULL
,	NULL
Haseltine	NULL
W	NULL
:	NULL
A	NULL
transcriptional	NULL
activator	NULL
protein	NULL
encoded	NULL
by	NULL
the	NULL
x-lor	NULL
region	NULL
of	NULL
the	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
.	NULL

Science	NULL
228:1430	NULL
,	NULL
1985	NULL
51	NULL
.	NULL

McKinsey	NULL
TA	NULL
,	NULL
Brockman	NULL
JA	NULL
,	NULL
Scherer	NULL
DC	NULL
,	NULL
Al-Murrani	NULL
SW	NULL
,	NULL
Green	NULL
PL	NULL
,	NULL
Ballard	NULL
DW	NULL
:	NULL
Inactivation	NULL
of	NULL
IxBB	NULL
by	NULL
the	NULL
Tax	NULL
protein	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
:	NULL
A	NULL
potential	NULL
mechanism	NULL
for	NULL
constitutive	NULL
induction	NULL
of	NULL
NF-kB	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
16:2083	NULL
,	NULL
1996	NULL
MORI	NULL
ET	NULL
AL	NULL
52	NULL
.	NULL

Good	NULL
L	NULL
,	NULL
Sun	NULL
S-C	NULL
:	NULL
Persistent	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

by	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
Tax	NULL
involves	NULL
degradation	NULL
of	NULL
I	NULL
«	NULL
BRB	NULL
.	NULL

J	NULL
Virol	NULL
70:2730	NULL
,	NULL
1996	NULL
53	NULL
.	NULL

Li	NULL
C-CH	NULL
,	NULL
Ruscetti	NULL
FW	NULL
,	NULL
Rice	NULL
NR	NULL
,	NULL
Chen	NULL
E	NULL
,	NULL
Yang	NULL
N-S	NULL
,	NULL
Mikovits	NULL
J	NULL
,	NULL
Longo	NULL
DL	NULL
:	NULL
Differential	NULL
expression	NULL
of	NULL
Rel	NULL
family	NULL
members	NULL
in	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
-infected	NULL
cells	NULL
:	NULL
Transcriptional	NULL
activation	NULL
of	NULL
c-rel	NULL
by	NULL
Tax	NULL
protein	NULL
.	NULL

J	NULL
Virol	NULL
67:4205	NULL
,	NULL
1993	NULL
54	NULL
.	NULL

Lanoix	NULL
J	NULL
,	NULL
Lacoste	NULL
J	NULL
,	NULL
Pepin	NULL
N	NULL
,	NULL
Rice	NULL
N	NULL
,	NULL
Hiscott	NULL
J	NULL
:	NULL
Overproduction	NULL
of	NULL
NF-	NULL
«	NULL
B2	NULL
(	NULL
lyt-10	NULL
)	NULL
and	NULL
c-Rel	NULL
:	NULL
A	NULL
mechanism	NULL
for	NULL
HTLV-I	NULL
Tax-mediated	NULL
trans-activation	NULL
via	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
signalling	NULL
pathway	NULL
.	NULL

Oncogene	NULL
9:841	NULL
,	NULL
1994	NULL
55	NULL
.	NULL

Baba	NULL
M	NULL
,	NULL
Imai	NULL
T	NULL
,	NULL
Yoshida	NULL
T	NULL
,	NULL
Yoshie	NULL
O	NULL
:	NULL
Constitutive	NULL
expression	NULL
of	NULL
various	NULL
chemokine	NULL
genes	NULL
in	NULL
human	NULL
T-cell	NULL
lines	NULL
infected	NULL
with	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
:	NULL
Role	NULL
of	NULL
the	NULL
viral	NULL
transactivator	NULL
Tax	NULL
.	NULL

Int	NULL
J	NULL
Cancer	NULL
66:124	NULL
,	NULL
1996	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

®	NULL
blO	NULL
0d	NULL
1999	NULL
93	NULL
:	NULL
2360-2368	NULL
Constitutive	NULL
Activation	NULL
of	NULL
NF-	NULL
«	NULL
xB	NULL
in	NULL
Primary	NULL
Adult	NULL
T-Cell	NULL
Leukemia	NULL
Cells	NULL
Naoki	NULL
Mori	NULL
,	NULL
Masahiro	NULL
Fujii	NULL
,	NULL
Shuichi	NULL
Ikeda	NULL
,	NULL
Yasuaki	NULL
Yamada	NULL
,	NULL
Masao	NULL
Tomonaga	NULL
,	NULL
Dean	NULL
W.	NULL
Ballard	NULL
and	NULL
Naoki	NULL
Yamamoto	NULL
4	NULL
_	NULL
5	NULL
,	NULL
'	NULL
_	NULL
>	NULL
,	NULL
#	NULL
04	NULL
;	NULL
©1004	NULL
@	NULL
207	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/93/7/2360.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Neoplasia	NULL
(	NULL
4182	NULL
articles	NULL
)	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

